Content-Type: text/html

Reference sequence (query): batch____
Identities normalised by aligned length.
Colored by: property
HSP processing: ranked
Search cycle: 2
                                                                                                      1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :  ] 253
    batch____                                              bits   E-value  N 100.0%   1:253             MRILLSNDDGVHAPGIQTLAKALREFADVQVVAPDRNRSGASNSLTLESSLRTFTFENGDIAVQMGTPTDCVYLGVNALMRPRPDIVVSGINAGPNLGDDVIYSGTVAAAMEGRHLGFPALAVSLDGHKHYDTAAAVTCSILRALCKEPLRTGRILNINVPDLPLDQIKGIRVTRCGTRHPADQVIPQQDPRGNTLYWIGPPGGKCDAGPGTDFAAVDEGYVSITPLHVDLTAHSAQDVVSDWLNSVGVGTQW    
  1 UniRef50_A1ASL7        5'-nucleotidase surE n=3 Ta...   337     3e-91  1  47.5%   1:244   1:246     MHIMVTNDDGIQAPGIQALASALRVLGEVTVVAPDRERSAVGHALTLNSPLRVFELRD-GFYAVDGTPTDCVNMGIHSLLPFRPDLIVSGINHGANLGDDVTYSGTVAAAIEATLMGIPAIAVSLATQehFPEAAQIAVRVARQVLSNGLPEDTFLNVNVPDCPAEEIRPPLVTRQGKRSFVGNVIDKTDPRGRKYYWIGSGEADFNDYEGTDFHAINRKHVSITPLHLDLTNYASMKVITTWV---------    
  2 UniRef50_A0KGH8        5'-nucleotidase surE n=8 Ta...   333     4e-90  1  62.0%   1:245   1:250     MRILVSNDDGVHAEGIRALSEALTACGEVIVVAPDRNRSGASHSLTLEVPLRVTRLGETGfyAVKGTPTDCVHLAVNELVRPEPDMVVAGINHGANLGDDVIYSGTVAAATEGRHLGFPSLAISLVGKTHFATAAHYAAQLVKGMMVHPLPADQILNVNVPDLPLDQIKGIRVTRLGNRHRAESVICSEDPRGQPIYWIGPPGSQQDAGEGTDFAAIEQGYVSITPLTIDMTAYSSLAGLGAWLD--------    
  3 UniRef50_A5F9D9        5'-nucleotidase surE n=205 ...   332     5e-90  1  55.3%   1:246  14:259     MKILLSNDDGVYAQGIHALADALRDLAEIVIVAPDRNRSGASNSLTLEHPLRVSQIAENT-YSVQGTPTDCVHFALNELMKDapDLVLSGINHGANLGDDVLYSGTVAAAMEGHFLGVQSIAFSLAGTTHFASAAHFVRQLVEQHLANPIPTNRLLNVNIPDRPLELIQGIEVTRLGARHHAESMIKQKDPRGHDIYWLGPPGKEQDAGPGTDFHAIERGWVSLTPLQVDLTAHESLRSMDHWLKE-------    
  4 UniRef50_B0TAY4        5'-nucleotidase surE n=10 T...   332     5e-90  1  46.7%   1:246   1:252     MRILLTNDDGIHAPGIHALWRIFDDWADIFVVAPDTERSATGHGITVHQPLRVEKLshCHGWAVNGTPADCVKLAMEELLAEPPHIVISGINRGPNLGTDVLYSGTVSAAMEGVIYGVPSIAVSVTGwaDYTVAAETTRLLCEKLVARGLTPDTFLNVNVPDLPRERIAGIQVTKLGSRRYQNIFDKRTDPRGRTYYWMAGEVHDVDAGEGTDISAVNAGAISVTPIHFDLTNYSLIQEVSDWLGG-------    
  5 UniRef50_A9N2D0        Exopolyphosphatase n=110 Ta...   330     3e-89  1  92.1%   1:253   1:253     MRILLSNDDGVHAPGIQTLAKALREFADVQVVAPDRNRSGASNSLTLESSLRTFTFDNGDIAVQMGTPTDCVYLGVNALMRPRPDIVVSGINAGPNLGDDVIYSGTVAAAMEGRHLGFPALAVSLNGYQHYDTAAAVTCALLRGLSREPLRTGRILNVNVPDLPLAQIKGIRVTRCGSRHPADKVIPQEDPRGNTLYWIGPPGDKYDAGPDTDFAAVDEGYVSVTPLHVDLTAHSAHDVVSDWLDSVGVGTQW    
  6 UniRef50_A5UHI7        5'-nucleotidase surE n=18 T...   329     4e-89  1  56.9%   1:246   1:245     MRILVSNDDGFHAEGIQVLATELRKIAEVIVVAPDRNRSAASSSLTLVEPLRPRHLDNGD-YCVNGTPADCVYLALNGFLSGQVDLVVSGINAGCNMGDDTIYSGTLAAALEGRHLGLPAIAVSLDGRQHYETAARVVCDLIPKLHHQLLNPREIININVPDLPFEELKGYKVCRLGYRASSAEVIKQKDPRDETIYWIGPSALPEDESEGTDFYAVKNGYVSITPIQADLTAYHSLLSLQNWLEQ-------    
  7 UniRef50_B3QYH6        Stationary-phase survival p...   329     8e-89  1  36.0%   2:243  25:271     -KILVTNDDGIDAEGIRVLAQSMQRIGDVTVVAPASPQSGMSHAMTLGRPLRIQKVYKNkgYSVSGTPVDCVKVAMTHILKDRPDLVVSGINYGSNTAINILYSGTIGAAVEGRIYEIPSIAFSlyENADFSYAGKVARQIAKKVLEKGLPPRTLLSVNIPNVPESDIQGIVVTRQGRSCWQESMIEHHDPYGQPYYWLNGMMALYDDKLTDDEYAIRHNYVSVTPLRFDLTNYDFMESLTSW----------    
  8 UniRef50_Q0AXU4        5'-nucleotidase surE n=1 Ta...   328     1e-88  1  42.3%   1:248   1:254     MRILLTNDDGIHARGIQALIGELGSIAELFVAAPDRERSGTGHSITVFDPIKVIKAKLAGiwVIGGTPVDCVKLASSKLVGDNIDLVVSGINHGPNLGTDVLYSGTVSAAVEGVIMGSPSIAVSLNsdTDFSFAARFTRQVIQNLFKNGMEKKTLLNINIPYLCPQDIKGIRITRLGVRNYENLFEERHDPRGNTYFWMGGGVLEEPQEEDSDVNAVQHSYISITPIHFDLTDYHLVEQYRKSFSQFS-----    
  9 UniRef50_C6M3Z2        5'/3'-nucleotidase SurE n=2...   320     3e-86  1  45.6%   1:248   1:249     MNILISNDDGYLAPGIAILARVAAEFANVRVVAPERDRSGVSNSLTLDRPLQIKEASN-GFYYVSGTPTDCIHVGQHALPDFKPDLVLSGINNGANMGDDTLYSGTVAAATEAYLMGIPAIAFSLNDSryWKTAEKSVWMLLEYLLKNPPKEPILWNINIPAVMPEDIQGIKITRLGRRHHEQSIVPMHNPRGEPIYWIGPVGNISDQEKGTDFGECEAGFITITPLQIDLTAYNQLQSVNEFWQGIK-----    
 10 UniRef50_Q8RA90        5'-nucleotidase surE n=2 Ta...   320     4e-86  1  41.9%   3:243   6:251     --VLLTNDDGVQAKGILYLAEYLKENgdVVVVAPEKERSAISHAITLHKPLrvREEENLRIYAINGTPSDCVKMGIEVVMEKNPDIIISGINNGLNMGTDILYSGTVSAAIEGALYGIPALAVSLEEDGDFEEQRMYikKLIEKVLEEGLPKNTLLNVNIPDF-RKGINGIRITILGKRIYTETFQKNYDPRGKEYYWMAGKISEIDNDERTDIVSVKKGYISITPIHFDLTDYEAVKKLSSW----------    
 11 UniRef50_A0M5L6        5'-nucleotidase surE n=30 T...   319     6e-86  1  37.8%   3:243   8:256     --ILVTNDDGITAPGIRTLVEVMKELGDVIVVAPDSPQSGMGHAITISDTLFCEQVTIKESysCSGTPADCVKIATQEILHRKPDLCVSGINHGSNSSINVIYSGTMSAAVEAGIEGIPAIGFSLLDYsdFEPTRKFIKTITKNVLKNGLPIGVVLNVNIPKLKEAEIKGIKVCRQANAHWEEEFDKRTNPQGREYYWLTGKFVNKDEGKDTDEKALEEGYVSVVPVQFDLTAHHFIKDLSSW----------    
 12 UniRef50_A3J2F7        Acid phosphatase, survival ...   317     2e-85  1  35.7%   3:243   6:253     --ILVTNDDGIIAPGIRALISVMKELGEVVVVAPDSPQSAMGHAITINDTLKLTKveVEKEYSCSGTPVDCVKIAVNEILKRKPDLCVSGVNHGSNSSINVIYSGTMSAAVEAGIEGIPAIGFSLLDYsnFEPIKSHIKKIASEVLKNGLPEGVILNVNFPKLAKEDIKGTKICRQAKAMWQEEFDKRTNPHGKDYYWLTGKFVNLDKGTDTDEWALENGYISIVPVQFDLTAHHAMQQLNSW----------    
 13 UniRef50_B2A4J5        5'-nucleotidase surE n=10 T...   317     3e-85  1  39.9%   1:243   1:255     MKVLLTNDDGIYAPGIFAMAKEirDEFEAVVVAPDREQSATGHAITVHKPLRVNNVkeIPFYSVNGTPSDCVKLAVESVMDEKPDLVISGINRGANLGTDVLYSGTVSGAMEAAILNIKSIAVSlyDYEDYSTAASYTAYIANIIKDNpfENGTLLNVNVPAVEANQLKGVKITRQGFRQYENIFEKRFDPRGKAYYWMAGKVIEDTSDIKTDVASVKENYVSVTPIKYDLTDYNLYNSLSNW----------    
 14 UniRef50_C5TPI4        5'/3'-nucleotidase SurE n=6...   314     2e-84  1  45.3%   1:247   1:248     MNILISNDDGYLAPGLAVLARVCAEFANVRVVAPERDRSGVSNSLTLDRPLQLKQAEN-GFYYVNGTPTDCIHVGQHALADFKPDLVLSGINNGANMGDDTLYSGTVAAATEAYLMGIPAIAFSLADsrYWETAEKAAWILLSYFLKRPISEPILWNINIPAVAPEDIQGIKITRLGRRHHEQSIVPMYNPRGEQIYWIGPVGDVSDSEEGTDFGECASGFITITPLQVDLTAYGQMEQTASFWSEI------    
 15 UniRef50_A8UY79        Stationary phase survival p...   314     2e-84  1  41.8%   3:241   4:245     --ILVTNDDGYFSEGIKALREALKPLGRVVVVAPDRNLSGVGHSLTFTMPLRMRKVDEDFYTVIGGTPADCIHLGYHVILeeKPDLVCAGINEGPNLGEDITYSGTVSGAMEGRILGIPSVAFSAFGREefSEVAKSCRRVVEKVLEVGMPEDTYLNVNVPNLSSEEVKGIRLTRQGKRDYREKVFRYITPYGEPLYWIAAEEFGWSPEEGTDYWAVINGYVSVTPLQLDLTNYGAFKDIK------------    
 16 UniRef50_C1SH37        5'/3'-nucleotidase SurE n=1...   314     2e-84  1  40.5%   1:242   1:247     MRILLANDDGIYSEGIYALYKKLTEIADVTVVAPITEQSAVGHAITVADPLRvyKFGEFFGYGIKGSPADCVKIAISDIMDRKPDLVVSGINHGANLATNVIYSGTVSAATEGAMMGVRSVAVSLATKedFTTSAEIGAYFAKYMYSSSLPDNAVLNINVPALSKERIKGWRFARQGNSKYLDTFAKRTDPRGGSYYWLTGEKVEIDVTPESDEYMVENGYVSVTPLMFDMTDYRMYDQLKD-----------    
 17 UniRef50_B8FC91        5'-nucleotidase surE n=1 Ta...   314     2e-84  1  38.7%   1:243   1:248     MHILVTNDDGIHHPGLAALRDGLARDHRVQVVAPDRERSAIAHAITLLTPLRatNGNGIPSWAVNGTPADCVKLGVLELLGEKPDLVVSGINPGPNVGVNLNYSGTVSAAREAALLGIPAIAVSVSNptHFSDAARFMQDLVADVAERGLPKGVFLNVNLPDVPMEEIAGVRICRQGIARLEEAFHVRKDPRNQPYYWQGSETQLFGESPDEDGVALRENCIAVTPVQCDMTDYGFLNQLKEW----------    
 18 UniRef50_Q1Q1F9        Similar to acid phosphatase...   313     2e-84  1  40.3%   1:243  16:264     MQILLTNDDGIYAPGIASLKHYIQDLGTVTVVAPDIEQSGVGHSITFNQPLRIRKVheFIGYGVNGSPADCVKLAVNEIMREKPDIVISGLNMGANVGIHILYSGTVAAAVEATVMGFSSIAVSFEITEHYDdtADVAKGIIQRILSHNLPKNLLLNVNIPAIPPDQIKGIKITHQFTQDFKEVFQKRIDPSGRAYYWLTGADKSKYHEEGTDLSALRDGYISITPLRYDRTDYQHHKIIEGW----------    
 19 UniRef50_D0JBF9        Acid phosphatase, stationar...   313     3e-84  1  32.8%   3:243   7:255     --ILVTNDDGIIAPGIRALVQSMNSLGDVYVVAPNKPQSGVGHAITMDTVLYCDSigNQKEWECSGTPVDCVKLAIDKILPKKPDICVSGINHGSNSSINIMYSGTISAVIEASIEGIPSVGFSldWNADFEPSKKYVYQIVKKILYNPIPEKIilNVNIPKLKKEQIKGIKICRQAGSKWKESFDKRSNPKGRTYYWLGGDFVNFDEKIDTDEWALKNGYISIVPIQFDLTNYPILNILKSW----------    
 20 UniRef50_Q1D402        5'-nucleotidase surE n=3 Ta...   312     8e-84  1  41.3%   2:243   7:249     -RILVSNDDGYFSEGLQALVEAVSPLGEVWVVAPDREQSAASHAISLHRPLRIKEVRE-RWFAVDGTPADCAYLAINHLldDRPVLMVSGINHGANLAEDIMYSGTVAAAMEGALLGVPAIAFSLVARRNFDFaaRFARSLVSSALSRPLPPRMLLNVNIP--GGVEPEGYVVTRQGRHSYGFEVVENEDPRGRKYYWIGGSDYQHEDIPGSDCNAvrDKRVSVTPLHFELTDHGRLPDLSGW----------    
 21 UniRef50_A7HLM0        5'-nucleotidase surE n=13 T...   310     4e-83  1  36.2%   1:246   1:254     MNILLVNDDGVTAPGILCAARYLSKEHYVVVSAPESEQSAVGHGITLRFPLWARKlePFEMYAVSGTPADCVKIGLDVIYKDkpDVVISGINRGENLGTDVVYSGTVSGALEGAIAGVPSIAISVADFKdyETGARFLLNFLKEFDVKRIPRFTALNINVPSVPYEQIKGWKLTRQSKRRYEDYFEKRIDPYGKDYYWMLGDIIEDDPDPKADYKALKEGYISVTPITIFMTNEELLKELEGIYGD-------    
 22 UniRef50_B8CWH0        5'-nucleotidase surE n=1 Ta...   308     1e-82  1  41.3%   1:247   1:255     MNVLLTNDDGVYAEGIFILASYLVSAGhvVVSAPDRERSATGHAITISYPLRAYKigEIDVYKIDGTPADCVKLGVEKLAGFKPDIIISGINDGPNLGYDVLYSGTVSAAIEGWMMGYTSIAVSLNSNghFKTGADFIVRLLNNFDFLSLDQKMLLNINIPDLPGEKINGIKITKLGKSLYEDSFEKRFDPMGKPYYWLTGNNVDNNIHDSTDIWAIKNNYISITPLKIDLTDLSQIDILNHNLNNL------    
 23 UniRef50_Q30YV9        5'-nucleotidase surE n=3 Ta...   308     1e-82  1  38.1%   1:252   1:257     MFIALTNDDGIQAPGLRAMYKALKEAGhvQVVAPVTEQSAVGHAVTIALPLRVKIFAENGfmGVYGTPTDCVKLGLNALLDKKPDIVVSGINAGANVGPDILYSGTVSAATEAAHMGYPSLAVSYDnpDDIAAHARFAVEIMESMPWQSLPPRCVLNLNLPDVPMQQCKGLTLCPQTRAVWKDWYDHRTDPRGNSYWWLNGIIPPETVAEGTDRDMLTRGYATLTPLRFDFTDRETLARLQQNMDRQRQGSE-    
 24 UniRef50_A6TRH0        5'-nucleotidase surE n=1 Ta...   307     2e-82  1  38.7%   1:243   1:250     MRILVTNDDGIFAEGIYVLAKSLQDVGEVIVVAPNTERSAVGHGITMHHPLRMAGvtSIEAYSVNGTPADCIKIAIEVLldRKPTVVVSGINNGPNLGTDVLYSGTVSAAVEAAILDLPSIAVSMATSkqYNHAAEFICKLLSNTLHIEELSDTIINVNYPTIAYSEIKGVKVTNLGIRKYENAFIERLDPRGNAYYWISGKAMELAQDHESDVQAINDNYISITPIHFDLTHFKSFKKLKNL----------    
 25 UniRef50_A3ZQ54        Survival protein SurE n=2 T...   307     3e-82  1  35.4%   1:243   1:248     MEILLTNDDGIYAPGLAAMERQLQKLGNVTVVAPATEQSGVGHSITFLSPLVCKEAYDgrGYAVEGSPADCVKIGVFEFCKKRPDLIVSGINGGLNAGINVLYSGTVAAAIEGAFFGITSVAVSLEWDEnfDVAALKGREIIEKILAQKGEPAQLFNLNFPTAALRKKSIVQVVPMGLARYGEHFIKRKDPRGRDYYWSTGDPKPEHGSEETDLSALEKGDITLTPLHFNLTESAYLDRMKSW----------    
 26 UniRef50_B8FYS8        5'-nucleotidase surE n=2 Ta...   306     5e-82  1  43.3%   1:245   1:245     MHILLTNDDGYFAPGLQTLYTTLAEAgdVFIVAPDSQKSATGHSITLFEPLFITklDRGTGYAVSGKPADCVKLAIQGSIIPKPDLVISGINNGPNLGTDVFYSGTVSAAMEGVLLGVPAIAVSLASFsdYKPAAQFVALSLPKLRLGPG----LININIPPLPEKEWKGVRVTKLGKAVYENVFEHRQAPYGRDYYWQAGT-VSPEVDQETDLYAVQEGYVSITPMHSDLTDYIKLKELRQSLS--------    
 27 UniRef50_D0MKC6        Stationary-phase survival p...   306     5e-82  1  43.2%   3:243  12:260     --ILVCNDDGINAPGIAALAAAMDALGEVYVVAPATEQSAVGHAITVRDPVRAYPwgEVPAYAVSGTPADCVKLAVNQLLPRRPDLVVSGINRGPNTAVNVIYSGTVSAATEAAILGIDAIAFSLCNwrDYSAAAHYARRIARTVLAHGLPPGILLNVNIPDLPLEKIKGIAITRQARSRWEESFAERRDPYNQPYYWLTGRFVNLDDGDDTDLEAVEQGYVSITPLQHDLTAHAYRAMLNQW----------    
 28 UniRef50_C6XTC8        Stationary-phase survival p...   305     9e-82  1  36.4%   2:243  15:261     -NILVVNDDGITAPGIKNLIDVMTELGNVVVVAPDGPQSGMGHAITIGKPLRFDAVdgVEMYKCSGTPVDCVKLAVNKIfgKKPDLCVSGINHGLNNSINVIYSGTMSAAVEGAIENIPSIGFSLDDFsdFSHCKKYIKVIAEQVLAHGLPAATLLNVNFPK--GDGLKGIKICRQANAKWAEEFDERKDPYERPYYWLTGVFQNYDKGEDTDVWALEHGFVSVVPVQFDLTAHHAIPVLNTW----------    
 29 UniRef50_C4GGR5        Putative uncharacterized pr...   303     3e-81  1  45.7%   1:247   1:249     MNILISNDDGYLSQGIATLARIAGEFANVRVVAPERDRSGVSNSLTLDRPLKIRSAEN-GFYYVSGTPTDCIHLGLHALADFQPDLVLSGINHGSNLGDDTLYSGTVAAATEAYLMGIPAVAFSLTSHEFHKYAakAVWNIVSRLVQNPPSAPILWNVNIPAVAPDQLRGHKIARLGRRHHTQSIVHATNPRGEDIYWIGAVGAVADNEQDTDFATCESGYVSITPLQIDLTAYSQMHALDEYWQGL------    
 30 UniRef50_C6HZU9        Survival protein SurE n=1 T...   303     4e-81  1  40.7%   3:243   8:254     --ILLSNDDGIDSKGIAVLEEAVEGLGEIYVVAPENERSAASHALTLHKPLRISERSPRH-FAVSGTPTDCVNLALFTILPRRPALLLSGINHGANMADDVTYSGTVSAAFEGSILGVPSMAFSlgEPLAFETARHFVRILAKRMLADSPPATIPFSVNIPSRPVDRVPGIRLTRLGKRIftGNIITKSDPRGRPYYWIGLSPTDYEPDPESDLHAVDHGYVSVTPLHLDLTHYPSLDRYRSW----------    
 31 UniRef50_A6CG83        Survival protein SurE n=1 T...   302     7e-81  1  40.2%   1:239   1:249     MQILLTNDDGIHAPGIRSLQKALTQLGDVEVVAPLSEQSGVGLSITYLHPLMIheSGKHWGWAVAGSPADCVKLGILEFCPQRPDLIISGINSGSNVGINVLYSGTVAGAIEGAFAGIPSIAISadTKPDYDRCAAQSIPIIRKLLQDPYPADRLWNLNFPEIRPDWPRGVKWTSLGVKRHFDVMEKRMDPRGRPYFWSGLDPIQNHqePGTDIHELSEGFVTVTPLKFDLTDHDHLQS--------------    
 32 UniRef50_C5RZW8        Stationary phase survival p...   302     8e-81  1  51.2%   1:244   1:258     MNILISNDDGINALGIKTLAATLREAGhvTVIAPDRNRSAASSCLTLTEPLRVHQFDEFNYTVIAGTPADCVHLALNGLFPNDFDLVISGINHGANLGDDIVYSGTVAAALEGRHLPLPCLAVSLvgNNHFETAAKVVLSLLPKLHKDLINPREILNINVPDLPYEQLKGVMITRQGKRSQAAEIVKSQDPRNGVIYWLGANGVAIDESEGTDFYAINHDYVSITPIQADMTAHRSLTDLQEII---------    
 33 UniRef50_A9B1D4        5'-nucleotidase surE n=4 Ta...   302     8e-81  1  43.4%   1:244   1:251     MNILLSNDDGVHSPGLLALKCQLEQLGCVTVVAPERNWSAGSHSRTLFAPLRVNEvdGSPALACDGSPADCVGLALLGVMDHRPDLVVSGINLGANLGHDVLYSGTVAAAMEGLVVGIRSIAVSLVDgsDFSVAADWARRIAATAMELQLPSDILLNVNVPQGSAEIVNDAKVTRLGHRIYRDELIKRLDPRGRPYYWVGGAAPDGKPDDGTDFGAVANNHVSITPLHFDMTNLDWVQRLSTAI---------    
 34 UniRef50_Q2S1H7        5'-nucleotidase surE n=1 Ta...   302     1e-80  1  39.3%   2:243  11:260     -RILLCNDDGIHAPGIQSLASALDGLGELFVVAPTTEQSAVGHAITVRDPVRAHREepIPAWGVTGTPADSVKLACHELLDAPPDLVVSGINQGPNTAVNVLYSGTVSAATEASILGLDSLAISLcsKPQFEVAGQWARRIVEWALDRGLPQGVLLNVNVPALSAEQIEGVALTRQARSRWEEGFERRTDPADRPYYWLAGTFVNLDDGPETDLSAIERGYVSVTPIQHDMTAHDAFEAFGTW----------    
 35 UniRef50_C1A8T7        5'-nucleotidase surE n=1 Ta...   302     1e-80  1  45.5%   1:246   1:251     MRILLSNDDGILAKGLGVLERAAESLGELHVVAPDREQSATSHSLTLHHPLRPVRLGERR-WQVDGTPTDCVMLACEALLEARPDFVLSGINHGPNMGEDVLYSGTVAAAMEGLALGIPAIALSFAGnaLLDTQVGAIRSLLHHLTGLpfPADTLLNVNLPAVPGDEIRGIRLTRLGRRVFSDSIARMKDPWGRDILWIGGGSVEWSGAPDSDFRAVHDGYISVTPLHLDLTHRDVLNTSTEWWQE-------    
 36 UniRef50_B0RTZ9        5'-nucleotidase surE n=20 T...   301     1e-80  1  56.3%   1:247   1:251     MRVLVSNDDGVDAPGIQILAEALRRAGhvMVVAPDRDRSGASNSLTLDVPIRTRRIDAQTC-AVAGTPTDCVHLALTGMLDYDPDIVVSGINNSANLGDDVIYSGTVSAAMEGRFLGLPAVAVSLVTqhHFETAARAAVEIVARLKADPLPADTILNVNVPDLAWADVLGFEVTRLGNRHRSEPCVPQSDPRGRTVYWIGPAGPEQDAGAGTDFHAVRTGHISITPIHVDLTRYQALDTVAGWVGGL------    
 37 UniRef50_Q2LUH7        5'-nucleotidase surE n=2 Ta...   301     2e-80  1  39.2%   1:245   1:251     MRYLLTNDDGIYARGLSALYSELSKDADCLIVAPEVERSAVGHAITLNRPlrTKKDGNFLGYAVSGTPADCVKIGIKELSEKPVDLVVSGINIGANVGINVIYSGTVSAATEGAILGVPSMAISLGtnADYTFAAHFARTMARFIMKYFEKKSVALNINVPALPVQDIKGYAVTRQGKARLIESFDRRVDPRERLYYWLAGETQLSeeEPDSDGSALSRGMISITPIYHDMTRYDALDGLKALLS--------    
 38 UniRef50_A7HXK5        5'-nucleotidase surE n=95 T...   301     2e-80  1  40.2%   1:249   9:265     LRILVTNDDGIHAPGLKVLEKIAHKLsdVWVVAPEDEQSGSAHSLSLANPLRVRKLTARK-YAVRGTPSDCVLMAVRHIldEQPDLVVSGINRGQNIADDVTYSGTIAAAMEGTQLGIPSIALSQAfnVKWSTAEHFAPDILKKLIAAGWPEEVLININFPDVVPGSVTGIEVTRQGKRDQsvRVEERIDARNNPYYWLGFERILSNPPQGTDLRAIYESRISITPLHMDLTHQKTAKALNDALGTLAQ----    
 39 UniRef50_C8W6F2        Stationary-phase survival p...   300     3e-80  1  38.3%   1:248   1:257     MRLLLSNDDGINAKGIKTLAERLSKTAEVFVVAPDRERSSTGHGITVYRPLMVTecKDVVAWSISGTPADCVKLGIDELLPARPDLIISGINNGSNLSTDVLYSGTVSAAIEGVINGIPAIAVSLANneDFSCAVGFTENMVSNFISTGMYPGVMLNINVPA---GKPSGVKVTQLGLRRYVNCFEKRTNPRGKVYYWLAGEPIDVETglDIDSKAVKDNFISITPIHFNLTHFDEIENLNKWVKELR-----    
 40 UniRef50_D0XW22        Stationary-phase survival p...   299     6e-80  1  38.2%   1:246   1:255     MRILLTNDDGIHAPGLKALETIARALSdvWICAPEYEQSGASRALTLSDPIRVRKLDDRR-FAVEGTPTDCVMMAVQQLIdpAPDLVLSGVNRGQNLAEDVTLSGTVAGAIEGMAHGIRSIALSQTMnaHWETAEHFGPGIVQRLLEVGWPADVVMNVNFPALPPEKVAAVEVTRQGFRdlLRNMEKRTDLRGRDYYWMGFSAKASEPAEGTDLRAVYEGKISVTPLHIDLTHHESVHKLKSLLGG-------    
 41 UniRef50_B2VA83        5'-nucleotidase surE n=5 Ta...   298     1e-79  1  40.1%   1:242   1:249     MkvFLTNDDGYQSKGLQAIRNRleENFRVITVAPDRNMSGTSHSLTFTRPLKIEKIEEDFYYIVDGTPADCVHLGLNVIlnQKPDLLISGINTGPNIGNDVFYSGTVGAAREGTLFCIPSVAFSVGsnPNFEDVSKVAVKIVKALLIKNLPKGTFLNVNIPTIPAEKIKGFLLTKQGRGAYKEEIVKYLSPSKEEYYWIGGEEALLEesPGTDYTAVKDGYVSITPIRLDLTDHKAIDILDK-----------    
 42 UniRef50_Q6FCV6        5'-nucleotidase surE n=1 Ta...   297     2e-79  1  45.3%   1:245   1:255     MNILIANDDGVFAPGIQALAHALKPLGRVVIVAPESERSGYSSALTLDRPLRPIQISE-DVWAVNGTPADCVYLSMNGLFDFEFDLVVSGINSGANLGDDVLYSGTVGAAFEGRLMKQPAIAVSLAGshDYAVAAKWVHDFIQKGLPN-LPPRHILNINIPDVAA--LKGERVTYQGLRAQSKPITSHVDPRGRQVYWIGLAGEAVTDPKKtdFFAVANGYVSITPIQMDATNYDILEDLQTYIG--------    
 43 UniRef50_Q3ATV8        5'-nucleotidase surE n=11 T...   297     3e-79  1  35.1%   2:243  22:268     -HILICNDDGIEADGIHALATAMKKVGRVTVVAPAEPHSAMSHAMTLGRPLRIKEYQKNggYTVSGTPVDCIKVALSHILTEKPDILVSGINYGSNTATNTLYSGTVAAALEGAIQGITSLAFSLATYedFTYATKFARKLTKKVLAEGLPADTILSVNIPNVPESQIAGVIIAEQGSSRWEEQAIERHDMFGNPYYWLSGSLQLMDHSMKKDEFAVRHNYVAVTPISCDLTNYAALAGLEKW----------    
 44 UniRef50_D0SVB2        5'/3'-nucleotidase SurE n=1...   296     4e-79  1  43.9%   1:246   1:256     MNILVSNDDGVFAPGIQALAQALKPLGRVVIVAPESERSGFSSALTLDRPLRPIQIS-PDVWAVNGTPADCVYLAMNGLFDFEFDLVVSGINSGANLGDDILYSGTVGAAFEGRLTKHPAIAVSLsqPQDYQLAAEWVHDFIARGLPV-LPERHIFNINIPDVT--ELQGEKVTYQSRRRQSKPVTSHIDPRGRQVFWIGLSGEAVADPkdSDFSAVANGYVSITPIQMDATNYESLRNLQTQLAE-------    
 45 UniRef50_B1XPE2        5'-nucleotidase surE n=32 T...   295     1e-78  1  40.3%   1:243   7:275     LNLLISNDDGISALGIRTLANTLAEAGhvTVVCPDRERSATGHGLTLHRPIRTEIVEgvTAWSCSGTPSDCVKFALSAVLKERPDFVLSGINHGSNLGTDVLYSGTVSAAMEGLLEGIHSIALSLADYtnFQPAADFAVKLLCQLMEKRpdAPVLLNINVPNLEKEKLAGVKITRQGLRRYIEQFQKRQDPRGKTYYWLSGEVIEELPQPdtDVQAIAAGYITITPLQYIMNDLHRIQTleDW----------    
 46 UniRef50_Q67NP4        5'-nucleotidase surE n=1 Ta...   293     3e-78  1  42.7%   3:243   4:252     --VLLTNDDGIFAPGINALRARMEQIpeVWAVAPDRERSASGHAITTYRPLFPVRVEIPGAVavTGTPADSAKLAIEAILPRRPDLVISGINRGANLGTDIFYSGTVAAALEGPILGIPALAVSLDssSDYSAAADFAAQLALKVLEEGLPEGTLLNVNVPALPREAIKGVRVTKVGRRIYRDQWVRRMHPRGQEYYWLAGELAEIHNDRESDVSAVEAGYISVTPVHLDLTRYDQMDRLRQW----------    
 47 UniRef50_B8DN39        5'-nucleotidase surE n=6 Ta...   293     5e-78  1  39.3%   1:252   1:256     MIVALTNDDGIQAPGLRAMYKALLDAGhvHVVAPVTEQSAVGHAVTISLPLRVKEFHENGFRgvYGTPTDCVKLGLSCLLDKKPDVVVSGINAGANVGPDILYSGTVSAATEAAHMGYPALAVSYDspADLSGQAAHAAGLLATLDWQALPARCVVNLNYPAVPMPEVKGVRACPQTRAVWKDWYDHRTDPRGGSYWWLNGVIPPETVAPGTDRALLTEGWITLTPLRFDFTDHEAMDVLAR-VQGDGVGGQ-    
 48 UniRef50_A8ZXL1        5'-nucleotidase surE n=1 Ta...   292     8e-78  1  39.1%   1:243   1:248     MNIVLTNDDGIDAEGLLALYRVFSRDHRVVVVAPEAERSAVGHGISLHQPLRVNQraGGEWYAVSGTPADCVKLGILALLDPRPDLVISGINAGLNHGAYMHYSGTVAAAREACVYGVPSIAVSMDGYpyFDEGASLTQTLVERLAEMEMPANTFLNVNMPDLPRERITGICFCSQDVLPPGDRVDMRNDPRGLAYYWYAYDNTHGDGTGDTDRAMLRNGTVSITPVTCDGTHYGVLERLKQF----------    
 49 UniRef50_A3M7F7        5'-nucleotidase surE n=15 T...   292     9e-78  1  44.9%   1:245   1:255     MNILIANDDGVFAPGIQALADALKPLGRVVVVAPESERSGFSSALTLDRPLRPIQIAE-DVWAVNGTPADCVYLSMNGLFDFEFDLVVSGINSGANLGDDVLYSGTVGAAFEGRLMKQPAIAVSLAGpdDYAQAAKWVHDFIAKGLPA-LPPRHIFNINIPDVP--QLKGTQITYQGRRAQSKPITSHVDPRGRQVYWIGLAGEAVTDPqqSDFFAVANSFVSVTPIQMDATNYAVLEDLQASLG--------    
 50 UniRef50_A1KUT0        5'-nucleotidase surE n=23 T...   292     1e-77  1  42.9%   1:245   1:246     MNVLISNDDGYLSEGIAVLARVTAEFANVRVVAPERDRSGVSNSLTLERPLQLKQAQN-GFYYVNGTPTDCIHIGQSVFSDFQADFVFSGINRGANMGDDTLYSGTVAAATEAYLMGIPAVAFSLnsGRYWATAEKALWTLLAHFFKNPPQSPILWNINIPAVEPEDVRGIKIARLGRRHHGQNVIPARNPRGEQIYWIGPVGRVSDKEEGTDFGECGAGFITVTPLQIDLTAYPDMAETAAFWH--------    
 51 UniRef50_A1TM17        Exopolyphosphatase / 3'-nuc...   290     4e-77  1  46.2%   1:249   1:254     MKILLSNDDGYQAPGIVALHAALREIpdVDVVAPEHNNSAKSNALTLHSPLYVHQAAN-GFRYVNGTPADCVHIALTGLLGYRPDLVVSGINNGANMGDDTIYSGTVGAAMEGYLFGVPAIAFSQvgWGEIEAAARKAREMVEQMHAQHleVPWLLNVNIPNLPFDQLRPVQVCRLGRRHAAERVIEQESPRGERMYWIGGAGPAKDDSEGTDFHATALGHVALTPLKVDLTDHEGLAYWSDTAGRLAQ----    
 52 UniRef50_D1R4R4        Putative uncharacterized pr...   289     5e-77  1  36.4%   3:249   9:262     --ILITNDDGIHAPGIKHLWQAISSFADVTVVAPATEQSAVSLSITIRNPLHIEKVtnVDVWSVSGTPADCVKLGLNVVLESPPDLILSGINRGTNAGRNVLYSGTVGGVIEGIMHNIPGIAFSCYDFHdyATAEKYIPLIVRHILQHPLPNGTFLNVNFPPKHLNEIKGIKLTRQGKEYWVENPDKREHPngNSYYWLGAKLAKFEEEADSDIPLLQQGYLTAVPVHveLTDHHHLTAHRDHFEQLSL----    
 53 UniRef50_Q2NDM8        5'-nucleotidase surE n=2 Ta...   289     5e-77  1  40.4%   1:245   1:252     MRILLTNDDGIHAPGFEVLEDIARELSdiWVCAPAEEQSGAGHSLTLHHPVRLRQLGERR-YSVTGTPTDSVMLALRTVLEDkpDLILSGVNRGANLGDDITYSGTASAAMEGALGGIKSIALSQVYKRdfDAARTYGADVIRKLIDAPFGDRTLININFPPLPADKVRGIRAVRQGFHDyrGSVVKGRDPRGLEYYWFGLYAIEHTLDHGTDLEAIDEGFVSVTPLQLDLTQHSLLSVIGERFE--------    
 54 UniRef50_B5YE72        5'/3'-nucleotidase SurE n=2...   289     6e-77  1  35.0%   2:241   5:247     -KILITNDDGINSPALKIMGKELSKLGEVYIIVPERERSGGSHAITLHKPLRVNEVKWpkVWSTNGNPADCVLLGLYAILSQKPDLVISGINKGYNLGNDIIYSGTVSGAREASLNGIPAVSISVSqeEDFKKATELLIRLFGKFLKI-IPEGTFLNINVP--PNAKVDEICFTYQGKFHYRNIVERRLDPRNKEYFWLHGYIEEI-GEEGSDIWAVKNGKISITPLQSDMTNYSLLNLLK------------    
 55 UniRef50_A5EY39        5'-nucleotidase surE n=1 Ta...   289     7e-77  1  44.0%   1:248   1:250     MFLLLSNDDGYASAGMRALVEVMEGAVelIVMAPESNCSGVSHALTLTRPLTVQTHGNA-IYSVNGTPADCVRVAVGGYFDEVPDMVISGINCGANLGDDVLYSGTVAAAFEGRYLKFPALAISNVAHrhLADTAQIVLDLFSFFKKNPLTGATLLNINIPDLPRAEIRGIRVTRLGQCRQERPLEKMINPRQEECYWIGANKGGFLADEGSDFAAIEQGFVSITPLQFDVTHDDQLEAVKHWLEPMR-----    
 56 UniRef50_Q2RTH6        5'-nucleotidase surE n=6 Ta...   288     9e-77  1  40.7%   2:244  12:261     -RILLSNDDGFEAEGLAVLERVARTLSdvWIVAPETEQSGAGHALTIHDPLRFRARGEKR-FSVRGTPTDCVLVAVNHLMDRPPDLVVSGINRGGNLGEDVHYSGTVAAAMEGTLLGLRAIALSQVFETnfQVAATHASDVIRRVCGRPWNRQVLINVNFPDCPLDAVTGIELKRQGRRKMGDDIEERRDPRDRPYLWIGAQRKEDRKTAGTDMEAISRGAITVTPLCVDMTDLPTIEALTGAF---------    
 57 UniRef50_Q72A55        5'-nucleotidase surE n=5 Ta...   287     2e-76  1  37.4%   1:243   1:248     MRIALTNDDGIQAPGLRAIYKALIEAGhvDVVAPVTEQSAVGHAVTIAMPLRVKVFHENGFRgvYGTPTDCMKLGLSSLLEHKPELVVSGINAGANVGPDILYSGTVSAATEAAHMGYRAVALSYDspEDISAHARHAAALLPHIEWAGLPERCVVNINYPAVPVESIKGVRVCPQTRAVWHDWYEHRTDPRGGSYWWLNGVIPPETVAPGTDRALLTEGYITVTPLRFDFTDSETLTRLASL----------    
 58 UniRef50_Q5HWH7        5'-nucleotidase surE n=18 T...   287     3e-76  1  35.5%   1:245   1:254     MkiLITNDDGYESEGLKKLIKMLTKeaKITIVAPASEKSACSHSITLTKPLRFVKVGKRFYKLDDGTPADCVYLALHALYKKrpDLVISGINKGANVGEDITYSGTCAGAMEAVLQGIPAIALSQFYKkdYKNALQITKKIIQNIFDKGFpkKEFLNINFP--AKSKIKGIKICKAGKRVYNFEAHSNVNPRGVEYYWLAAANLDFEDEKNSDIALLKKGYATITPIMLDLTAYERMKKVKKWLK--------    
 59 UniRef50_D1AMG3        Stationary-phase survival p...   287     3e-76  1  36.7%   1:245   1:254     MKILLSNDDGIFAKGIETLAMVLIERGhvYVVAPDEDASGTGHGLTINKPLRYRKygNFFGYMVNGKPADCVKLARWEIYRddFDFMISGINRGANLGVDLFYSGTFGAASEAALLGVRSIALSLSEpkNYLTAAVFAADFIEKIKDFQFPRYKLLNINVPNVKTEELKGYKFTIQGDRNYKENFDKRFDPNGHEYFWITGNAVEYSSNYHSDYYVLKDNYVSITPVALDLTDEKFGLQIEKELN--------    
 60 UniRef50_B9MFW6        5'-nucleotidase surE n=107 ...   286     4e-76  1  47.7%   1:237   1:240     MKILISNDDGYQAPGIVALHDALKTIADVEVVAPEHNNSAKSNALTLHSPLYVQTAHN-GFRYVNGTPADCVHIALTGLLGYRPDLVVSGINNGANMGDDTIYSGTVGAAMEGYLFGIPSIAFSQvgWGEIESAARKAREIVQQMDRQNleAPWLLNVNIPNMPYDALRPLRMCRLGRRHAAERVIEQQSPRGELMYWIGGAGAAKDAAEGTDFHATAHGHVSVTPLKVDLTDYDGL----------------    
 61 UniRef50_Q7UKT6        5'-nucleotidase surE n=3 Ta...   286     6e-76  1  35.8%   1:243   1:249     MRILLTNDDGVHAPGLAALRQQLRHLGEVITVAPATEQSGVGHSITYLTPlsIHRDGVHWAWAVEGSPADCVKLSLAELfdEPIDLVVSGINNGLNAGINVLYSGTVAAAIEGAFFGVTSVAVSLENSDdfDAAAVIARNVIGEIVRHEESRGGLFNLNVPTAATESASEVKVVPMGLAQYGRRYEKRQDPGGRDYYWALWTQPDKPPAEMTDVTQLREGCVTLTPLHFNLTRDDLLSEMKDW----------    
 62 UniRef50_B0VI54        Broad specificity 5'(3')-nu...   286     6e-76  1  39.9%   1:243   1:245     MKILLVNDDGILAPGIRTLAEELKNAGhiTIVAPDSERSAASHSLSIRKELIVKKIAENE-YAVSGTPVDCSVIALQKILTEPVDLIISGINAGQNMGEDVLYSGTVGAAMEAALLGNRAIAVSINSYKnfEVAAYWMRKLLDLGIDKQAEAFGVLNINIPNLPLEEIKGIRLTRTGHRKYYNFVKIIKENEDGFVYEVGGDIPVWDNETGTDAEAVNNGYISLTPLGFELTRSETFPRILNW----------    
 63 UniRef50_Q1ATN8        5'-nucleotidase surE n=1 Ta...   285     9e-76  1  42.8%   1:243   1:257     MRIVLTNDDGIEAPGLLAARRALEEVGEVITVAPDRNRSGVGRSITFGAELYVEErdGGVGYACSGTPVDCVRlaLGMVEGFRPDIVVSGINHGENLGDDITYSGTVAGALEAIVIGVPGIAVSLSTGrhFEPVARFTARLAG-LALRDLPPGRILNVNAPNLPEEELEGARVTRLGRRFYQDELIEVRDKNGRVGYNIYNNPPGHHDEEGTDFAALQSRRISVTPVHLDLTDTAGLKELESW----------    
 64 UniRef50_C5RLV0        Stationary-phase survival p...   284     2e-75  1  37.4%   1:246   1:248     MRLLIVNDDGINARGIQILAKELHKHHEVIVAAPNVQRSASSHSITLNSTLTIKEEIVPEvySINGTPADCTRLAVEKLMNFEVDLVISGINDGYNLGTDVLYSGTVSAAIEAAVVGVPAIAISCDGTEefRRGAEYALKVIEKLKDNKLSENIVLNVNIPK--TEAVKGIKICSMGERIYKDVFFETLSEEGSRTYDIKGTPCDSD-DETTDVGIITKGYVTVTPLHYDLTNYNILKETEKVFSE-------    
 65 UniRef50_B0T1Q2        5'-nucleotidase surE n=8 Ta...   284     2e-75  1  36.4%   1:247   1:256     MRILLTNDDGIHAPGLGSLERIARMLSdiWIVAPEYEQSGAGRALTLSDPIRVRRIDPRR-FAVEGTPTDCVAMAMQQLIepAPDLVLSGVNRGQNLAEDVTLSGTVAGAIEGMAFGIRSIALSQAMtaHWETAEHFGPGIVQRLLEVGWPKDVIINVNFPAVAPEMVTEVEVTRQGFRdhMRSMEKRTDLRGRDYYWTGFVVKPSNPAEGTDLKAVYQGRISVTPLHIDLTHNQTVAAMKGALGGT------    
 66 UniRef50_B2UU78        5'-nucleotidase surE n=20 T...   283     3e-75  1  36.2%   2:247   3:265     -KILLTNDDGYHAKGIKALEQALEKMAEIYVVAPKHEKSACSQCITITAPLRAEKieGRHYKIDDGTPSDCVYLAINELFKHvfDLVISGINLGSNMGEDTIYSGTVAGAIEGTIQGVPSIAISqnTPLSFDLAQKIIQDLVQNIFTNGYpgRKLLNVNVPNCSLQEYKGECITPKGYRLYKKEVHKRTDPKNESYFWLGLHPLeeNEDRLSDFDAIASNHVSITPLNLDLTSYDDLKNLESWHKGM------    
 67 UniRef50_B6BWV8        5'/3'-nucleotidase SurE n=1...   283     4e-75  1  45.9%   1:244   1:243     MKFLLSNDDGYLAPGINELAHILSSIGEVVIVAPEENKSASSSSLTLKNPLTITEHKKN-IYYINGTPTDCVHIALSGFLKFKPDMVISGINDGPNMGDDTIYSGTVAAAMEGYLLDIPSLAISmyDPKYYATAGQVVLDLVPKIKD--LQQSMLLNINVPDLPYDQLKGLEITRLGKRHKAEPIIHHPNQNNKLMYWVGAAGEPNDGGPGTDFFAIKNEKVSISPIISDLTNFNKLDLLKENL---------    
 68 UniRef50_A5CVV1        5'-nucleotidase surE n=5 Ta...   283     4e-75  1  46.6%   1:247   1:246     MKILVSNDDGYQAQGIIELAQSLAQEHEVIVVAPSENKSAASSSLTLDKPLRPIQISNN-VYCIDATPSDCVHLALCGFLNEEIDLVVTGINFGANLGDDVIYSGTVAGAIEGRFLGLPSLSISLASWrhFKTAGIVIRQLINQISHAHLSYGTVLNINVPDVIFSDIKGFQTTRLGKRHMSE--QSVIDKNDSSLYWIGENGKEADNGVGTDFHAITNHYVSITPLQTDLTKYNEINTVSTWLNQI------    
 69 UniRef50_D1B9N2        Stationary-phase survival p...   281     2e-74  1  45.5%   1:242   1:252     MKVLMSNDDGILAPGIQIMAKVLADRgpCAVVAPDRERSSIGHAITLNRPLRVWHLEPgpAYACDGTPSDCVVIGVEELAKDVT-MVISGINRGPNLGDDLTYSGTVSAAMEGLILGYDAIAVSLACkaHYSTAAAVVVAFLDWFKQNHRQKGVLYNINVPNVPIRSLKGILPTKKGTRLYRDKVTKFRDPQGRECYWMGGVPEDR-LEEGTDVWAVSNGYASVTPIHMDMTHYDTLKEMSS-----------    
 70 UniRef50_C9MMA9        5'/3'-nucleotidase SurE n=5...   278     1e-73  1  33.2%   3:243   8:254     --ILISNDDGYHSNGIRTLVSFLTDFADVVVCAPESGRSGFSCAFSVTDYLLlhNIPNCEVWSCTGTPVDCVKLALDQLLKekPDLILSGINHGDNSSVNNHYSGTMGVAYEGCMKYIPSIAFsyNTEADLSYLRDYVRKIVKKVLTDGLPKGVCLNVNFPKV--EKFAGLKVCRMGFGSWTREVERCKHPRGFDYYwiGHYQNDEPDATDTDQWALNHGYVSVTPTRIDVTDYDMIEKMNTW----------    
 71 UniRef50_Q6MCW1        5'-nucleotidase surE n=1 Ta...   277     3e-73  1  36.2%   3:237   7:249     --ILVTNDDGVHAKGIRHLWQSIQDLADLIIVAPQQEQSAVSLSITVRRPLHIEKVdqADVWSVNGTPADCVKLALNVVLPKRPQLIVSGINRGTNAGRNIFYSGTVAAIMEGVMQGIPGIAFSYGdnPSYHLIESFIPGIVNYALQNAMQEGTFLNVNFPKTEHGPIKGIRLTTQGKEYWAENPEKRQHpeQNSYYWLGSKLAEYDEREDSDIFLLRKGFATVVPLHidLTNHSHL----------------    
 72 UniRef50_B0ACR2        Putative uncharacterized pr...   277     3e-73  1  39.7%   1:237   1:243     MNILISNDDGINAEGIKILAEEISKIANTYVVAPDSPRSASGHAITLHKPILINdaENVEAYSTSGTPADCVKVGIESILKdeIDLVLSGINNGPNLGTDVIYSGTVAAAIEGLVEGKPSIALSCDSSkeYREAAKYTAKLIQKLEGndKLNGNILNVNFP---TGEKKGVRITKLGRRVYNNVMDDRQSIRGQRYVWMGGDLEDIKQDKDSDIFAVENGYISITPVHINMTETNRI----------------    
 73 UniRef50_C5A6M8        5'-nucleotidase surE n=4 Ta...   277     3e-73  1  35.2%   1:244   1:255     MRILLTNDDGIYSNGLRAAVKALSELGEVYVVAPLFQRSASGRAMTLHRPIRAKRVDVPgaYGIDGTPTDCVIFAIARF--GSFDLAVSGINLGENLSTEITVSGTASAAIEASTHGIPSIAVSlgEGVDFSVSAHFLRRIAGAVLERGLPEGvmLNVNVPSDATEDTK-MAITRLARKRYSPTVEERIDPKGNPYYWIVG-RLVQDFEPGTDAYALkeRKVSVTPINIDMTARVDFEKLKNVL---------    
 74 UniRef50_C6XIZ8        Stationary-phase survival p...   277     4e-73  1  32.8%   1:247   1:255     MRILVTNDDGIDAPGLVVMEEIARSISdvWMVAPLVEQSGQGRAITVSEAVRIDQRGEKRFR-IEGTPTDCVVLGIEHIldKKPDLILSGVNNGQNVGEDTTQSGTIGAVVQGMLMGVPGIAFSqgKSMAWDTGRHFGPKVVKRLLETGWPKSVVMNVNFPDCEIEDVKGTEITSQGLRDFSinSEKRTDPRGRDYYWLSHGGPKSDPPGGTDLRCIYEDKISISPLHVDLTHYAYRDTLIESFGEL------    
 75 UniRef50_Q899M5        5'-nucleotidase surE n=2 Ta...   276     5e-73  1  34.4%   1:244   1:249     MRLLLTNDDGVNSKGIYTLAKELQKEHEIIIAAPSIEMSAKSHSITIAKPLFIKEVenATTYSISGTPADCVKVAMDKILDKPVDMVISGINYGTNLGIDILYSGTVSAAIEAAIHNIPSIAMSanGDINFDTAASIARELVKISQENSMKGNLVLNVNVPCLDKDSLKGLKVCQMGGRTFTSYFEKIE--KNKEVSYMLKGELTNNHKPTTDIHFLRKGYTTITPLHYDLTNFKIMNDVSNWF---------    
 76 UniRef50_C4V2A9        Acid phosphatase SurE n=1 T...   275     7e-73  1  35.2%   1:244   3:253     LNILISNDDGIAAEGIHVLARRLSGAHHVTVAAPMHQQSGTSHALTIGRAIEVREDENFDawAIDGTPTDCAKLYLDAIAEERPDVVLSGINHGSNLGTDVIYSGTVGAAFEGYFHGISSFalLDGSSLSFADAAEYFVPFMEQVLAA-ADQPFLLNINFPKELAGDEPRFVFCRQGGRDYVNAFERIEMEEGRVHYKVAGEVSDTDKGIGTDIYAVEHGLIAVTPLGVDMTDYPLLRQLGDAL---------    
 77 UniRef50_A5GUT4        5'-nucleotidase surE n=26 T...   275     1e-72  1  41.2%   1:240   5:259     LKILISNDDGVFAEGIKALAHEAARRGhvTVVCPDQERSATGHGLTLQSPIRAEQADgiRAWACTGTPSDCVKLALGKLLEAPPDLVLSGINHGPNLGSDVIYSGTVAAAMEGTLEGLPALAVSSadWRQFDGAAVQAMDVAESALAGGWPEGLLLNLNVPAVPPDRIGPVRWCRPGVRRYVDQFDERFDPRGRSYYWLAGEVVNDFEAAgtDVAQVQGGGVALTPLQPELFWRGALPPL-------------    
 78 UniRef50_D0LY90        Stationary-phase survival p...   275     1e-72  1  40.1%   1:237   6:244     MkvLLSNDDGIGSPYLQALADALDATGEvlVVAPERQRSAASHAITLHKPLRLHKHGERR-FSLSGTPVDCVYVGLIKLAERAPALVLSGINRGYNLGLDVFYSGTVAAAVEGGLRGVPAIALSLAPEedLQSALRFSVALALQVVANPLPPLTVLNVNFPVQPDERWA---WTGLGKRAYEDDVHERFDPRGQPYYWIGGGSAELGDDRCTDCAAIGAGITTVTPLRLNLSGHGLL----------------    
 79 UniRef50_C9KKZ7        5'/3'-nucleotidase SurE n=3...   275     1e-72  1  36.0%   1:242   1:258     MRILISNDDGIQAKGLEALVKAFCARKhvIVSAPARQQSGMAHALNVGRPLELVRGegIEAWAVDGTPTDSVKLYLEALAEEKPDVVVSGINHGANLATDILYSGTVGAAMEGMLHDIASFAVSmdSTISYEEAAEEFATILERVmaSDEPRPVFWNVNFptLGDDGRPQVVFGRQGKRDYHNAFQKQERTDGRIFYTVAGEIFDTDKSEPTDIYAVEHGYIAVTPLMVDLTDYVAIEKLLD-----------    
 80 UniRef50_Q8D2P7        Exopolyphosphatase n=1 Tax=...   274     2e-72  1  50.2%   1:247   1:247     MNILLSNDDGIYSPGIQKLSKKLKKFLNVQVIAPSCDKSGSSSSLTINNPLKVHKFSNGDITVYSGTPIDCVYLGINFFMKPKPDFVVSGINLGANLGDDVFYSGTVGAAMEGRYLKYSSLAISLDGNKHLDVAVEIVYKFLKFLLNNPFRKKYILNINIPDSPLKYIKGFKITKCGRKNFKNTVIKSKDSENKNIFWIGPKTNCYNESIGTDFHAIKNNYISVTPLLSNLTNNKEINSISNWFENF------    
 81 UniRef50_Q30QB8        5'-nucleotidase surE n=15 T...   274     2e-72  1  33.6%   2:245   4:264     -KILVTNDDGYEAKGLRALVKALKELEDvmVVAPASEKSACGHSLTLVRPLRFVGVDDNFFKLDDGTPSDCVYLALSTIydSKPDLLISGINRGSNMGEDITYSGTAAGAMEGVLHDVPSIAISqdPQGDFTLAQKVIKELVIKIKNgpLPQREFLNVNIpdSTDNRDAKMVVTYAGYRFYANDSHIHRNPRGEEFYWLGLHPLDFLPREgsDYEAIEAGNISITPIQLDMSAYKSMNKLKEWIE--------    
 82 UniRef50_C7P7T8        Stationary-phase survival p...   273     3e-72  1  34.9%   1:232   1:248     MDILIVNDDGIYSSSLIALYKALKEkaNITIVAPTNQQSGIGRAISLFEPLRMTKveNIFGYAVSGTPTDCVILGIYQILKKVPDLVISGINIGENLGTEIMTSGTLGAAFEAAHHGAKSIASslDIPINFEIPAKITARIAEKYLKYDMP-CDVLNINIPENATLE-TPIEITRLARKMYTTHVEERVDPRGRSYYWIDGYPI-FEEKEDTDVYVLrkGHISITPLTLDTT---------------------    
 83 UniRef50_C3JBG6        5'/3'-nucleotidase SurE n=2...   273     4e-72  1  36.3%   2:246   6:255     -HILISNDDGIHAPGIAALSTMLRTIGDVTVVAPEGARSGASSQITSSLPLKleEEEGYRVYRCTGTPADCVKLALNVLFSkrPDLVVTGINHGRNDGICVVYSGTVGAALEGCIAGIPSLAVSVNDHGDDAeaVAYTNTLVRWMLSNKIPTHTMLSLNLPSTTP---LGFKVAPQAVGRFRDEFLESTNGSGGRVYWMVGSQVKTEDEPNTDWDLLEEGYATLTPIRIDMTDRNFLPQLHEAFRD-------    
 84 UniRef50_B4UE89        5'-nucleotidase surE n=16 T...   273     4e-72  1  43.2%   1:243   1:243     MRVLLSNDDGVHAAGLKALADAFHGD-EVWVVAPDREQSASSHAISLHRPLRLLEVA-PRWYAVDGTPTDAVYMGLNLVLRdrPDVVVSGVNHGPNLGNDVLYSGTVAAAMEGALLGVNAVAVSLAAPpdFGEAARFAAALARQVVARPPPAPVLLNVNVPPGP---VRGYRFARLGRRTYGNEVVEKTDPRGRKYYWIGGEGRVHNEdpGSDCnvLLERLAAVTPLHLDGTHDPMFQELRSW----------    
 85 UniRef50_B1H035        5'-nucleotidase n=1 Tax=unc...   273     5e-72  1  38.6%   1:241   1:241     MhiLISNDDGVKAPGLRPLMKELSKIGKVYVIVPKTQMSGTGHGITLAKYKKVEKIEKDFYVIKGGTPADCVKYGLYHFFKNKTDLVVSGINTCPNLGQDVIYSGTVGAAREGALRGVPSLAVSAAEvtEYEHSAIATREIAEKVLKrkFFKNICLNINIPQ----NYKGIKVAPLGLRIYDESVETVVDERGNFSYRLSGKYISGGKNKGTDIDTVDKGYISVTPLRIDQTDFTFIKKLN------------    
 86 UniRef50_A6L1M6        5'-nucleotidase surE n=33 T...   272     7e-72  1  32.8%   3:243   8:253     --ILLSNDDGVEAKGLNELIRGLRGMGEIIVMAPDGPRSGASGAITSEHPVkvREEEDLTVYKCTGTPVDCVKLALHTVVPRRPDVVIGGINHGDNSSVNVHYSGTMGVVIEGCLKGISSIGYSLCNhaDFSSSLPYIRRITEQVLEHGLPLGICLNVNFPDTAS--LKGVRICRQTNGAWINEWKRSLHPRGGEYFWLTGEFDNYEPeeDSDHWALGHGYVAVTPTQIDVTAYGMMNELKNW----------    
 87 UniRef50_Q3ZXG5        5'-nucleotidase surE n=5 Ta...   271     1e-71  1  39.0%   1:228   1:235     MRILVSNDDGIYSPGLWALVKRLKEVGEVIVVAPDREQSATGTQVTLRQPLRVQkiPGIEAYAVEGSPCDCVILGLAKLITEPVDLVVSGINHGLNLGDDVLISGTVGAALQGYLRNIPSIAIsmEEPENLDSAACITAEVARRIQNGDITKNSFLNINIPDLPLSQIEELRVTPLAHKTHIETVEEGHDGR-KRYFWLRRRQLSSADNKKTDIWAIENGYITISALH-------------------------    
 88 UniRef50_Q5NNV1        5'-nucleotidase surE n=5 Ta...   270     2e-71  1  36.9%   1:244   1:253     MRILITNDDGIAAQGIKILEEIAHKISdvTVVAPDKERSGMAHSLTLSLPSRLYKHDDRH-YSVSGTPSDSVVMGIKEIMKdpPDLVLSGINHGANLAEDVTYSGTVSAAMEGAIAGIRSIGLSQVYSPdfDTAVSWGEKVIRQLIDSTLPNRTFYNVNFPACENDDVKGIRVVAQGHRDYGrnVEKGVDPRGKDWYWLALGEAISKDNLNGDLDLSYQNYVTVTPLAPNLTDVASLQPLTDIL---------    
 89 UniRef50_B6YUP1        Acid phosphatase n=2 Tax=Th...   269     6e-71  1  32.7%   2:246   3:258     -RILITNDDGIYSKGIRAAVEAVKDLGEVYVVAPLFQRSASGRAMTLHKPLRAKLVNVPgaYGLDGMPVDCVIFALARF--THFDLAISGINLGENLSTEITVSGTASAAIETATHGIPSIAISlgEGIDFSVASHFLRRITRTVLEKGLPKGvmLNVNIPNDATPE-TGIKVTRLARRRYRPTIEERIDPRGYPYYWIVGRKCEK-FEPGTDAYTLkeRKVSVTPINIDMTAGVDLKEVERLLRS-------    
 90 UniRef50_B7B5A0        Putative uncharacterized pr...   267     2e-70  1  32.9%   3:245  40:287     --ILITNDDGVEAKGIKELTECLRDLGDIVVFAPDGPRSGMASAITSLVPIrvKKEKGLTVYSCTGTPVDCVKLAINEVLERKPDLLASGINHGGNHAICIQYSGTMGAAAEGCVFGIPSMGVSLLDHrdFTESCRLGRMLARRIIKEGLPHGTYLNLNVPNVP--NVKGMKVCRQADGRWTNEFKRSENAAGEPVFWLAGaeNAKPIHADNDTLALDSGYASLVPCKIDVTDYDFLAVLKNQLK--------    
 91 UniRef50_Q12U23        5'-nucleotidase surE n=3 Ta...   266     4e-70  1  32.5%   2:244   4:261     -RILLTNDDGVYAAGIRAAYRSVSDLGDVTVSAPAQQQSGVGRSISIFEPLRITriDGIEVHAIGGTPTDSVILGIFTIMKELPDLILSGFNIGENISTdiTTSGTIGAALEGASYGVPAIAASldFQHDFDVGIKFVNGVAKKVLKNGLPENvlLNINIPHFVEEDSE-VEITRLARKFFRTGVEERRDPRGRPYYWIAGD-LIHTAEKGTDVNAIEKGHISVTPISLDATSPINFSEIEHLM---------    
 92 UniRef50_A9AAP6        5'-nucleotidase surE n=12 T...   266     5e-70  1  34.0%   1:247   3:264     MEILLVNDDGIYSNGLLALKNVISEeaNVTVVAPTNQQSGIGRAISLFEPLRITkaDCSEGYAVSGTPTDCVVLGVHQVLKKVPDYVISGINIGENLGTELTTSGTLGAAFEGAHHGAKALACSleSPIDFMTTARIVRNVFKKFLDDEFP-CDVININVPDNATEN-TPVEITKLARKMYSMHVEERIDPRSRSYYWLDGYPI-MDEEDGTDVYAVRnrNVSVTPLTLDNTAKNLDEFREKYAKKF------    
 93 UniRef50_Q0W2Q3        5'-nucleotidase surE n=2 Ta...   266     6e-70  1  34.7%   2:246   4:264     -RILITNDDGVASPGLMAVYEAVRSLGEAVIVAPASQQSAVGRSMTLFEPLRIEklQGTMAYAVNGTPTDSVIMGMYVVmdRKPDLVISGINIGENLSAevTTSGTIGAAMEAANQGVPAIAVSmaMAQDYAVAQRLIGKLARQVLENGLPEGvlLNVNIPAGATPE-TPVVVTRLARRMYDTIVHHRMDPRGRSYYWVDGTIVA-DAPEGTDLHTVHQRrvSITPLRLDMTACEQTVEIERIIRD-------    
 94 UniRef50_D1PB54        5'/3'-nucleotidase SurE n=4...   265     9e-70  1  30.8%   3:249  46:292     --VLISNDDGYHANGIKTLVSFLKDWCDLLVVAPESARSGFACAFSATTPLRLKRRhdVEVWSCSGTPVDCVKLALDQFldRKPDLIIGGINHGDNSSVNNHYSGTMGVAKEGCMQHIPSIAFsyDENADLTPLRDGVLKVVKMVLEKGLPEYTCLNVNFPALPP--FKGFKGCRMTHGSWINEVDHRTHPHGYDYYWmgEYRNDEPEATDTDQWAVNHGYIAITPTKIDVTDY-------DWLKNFEL----    
 95 UniRef50_Q2FLE8        5'-nucleotidase surE n=8 Ta...   265     1e-69  1  35.4%   3:245  23:277     --ILLTNDDGVNSEGLWAAYDALFEWADVVVCAPATQQSAVGRSLSIFEPLRVNTvgDITAYAVGGKPTDSVILALFAL-GVKPDLVVSGINIGENLSYeiTTSGTVGAALEAANHGYPAVAFSldQKEKFDDARhvVRDVIRRILEKGFPSFtvMNVNIPSIITG---GYEITHLAEHLFITGVEKRLDPRGKPYYWING-PLVTDAPEGTDVHAIHKGNISITPITLDCTAYAGTDDLRRLFS--------    
 96 UniRef50_Q8TY72        5'-nucleotidase surE n=1 Ta...   263     5e-69  1  34.7%   1:248   1:256     MRILITNDDGIASPGLRAAVRACRSVGEVTVVAPATQQSGVGRSISLLEPVRVEevEGVDALAISGTPADAVLIGAFSIMDEPPDLVVSGINLGENVSADVTTSGTVGAALEAYGNGIPAIAISqaKNVDFTLAIRVLKALLEAIRGANWEG--VLNVNVPD--PDRWNgiKVVPLAFTMYRPRIEKRYDPRGRRYYWIDGE-IIQDPPEGTDLYELQRGSIVITPLTTDVT--GDLDAAENVIKELR-----    
 97 UniRef50_D1YY71        5'-nucleotidase SurE n=1 Ta...   263     6e-69  1  32.9%   2:244   4:261     -RILITNDDGISSSGLLAAYESVKGLGEVTIVAPATQQSAVGRSMTLFNPLRLTRLkgTTAYTVSGTPTDAVIIGMFVAMKKKPDLAISGFNIGENLSTeaTTSGTIGAALEAAGQGVPAIAVSmnFKRDYSAAINVVGKLAQCVLEGKLPAGvvLNVNVPAHAGPK-TPVVVTKLARKMYDTRVHRRKDPRGRSYYWIDGTIVE-DAAEGTDLHTikKGMISVTPLTMDMTSPSNTKGLEKML---------    
 98 UniRef50_C2MAB7        5'/3'-nucleotidase SurE n=1...   261     2e-68  1  38.3%   1:243   1:250     MKILLTNDDGVHAQGIRELAETLAQIATVTVVAPTEPRSGASSQITSRTPLRITLMEESelYSCSGTPVDCVKLALNTIFATtpDLVVSGINHGRNDGICAIYSGTAGAAIEAAIARIPAVAFSLADHsdFSEVCAFAKQFIPQVMEHGLPRTTMLNVNFPKAPA---KGIKWAPQGTGRFVNEYMRSETPHGTPVYWMQGDQVDPDHRTGTDHYWLVEGYATIAPLQIDMTDHPFLERakEW----------    
 99 UniRef50_UPI0001C30ED4 stationary-phase survival p...   261     2e-68  1  42.0%   1:243   1:258     MKVLLTNDDGIEAEGINALRRALVELpeLLVVAPDGNRSATARSITTRRPLWVEEVdgTIGYATDGTPVDCVRLTRLGLVefMPDIVVSGINHGLNIGDDVTYSGTVAAAFEALLLQLPGIAVSQQSTadFSAAAAFTARIVEELDSVPFETGTLLNVNVPGMHPD---GAEVTRLGKRFYRDVLedEAHPR-RRRFHIYGDAQDLVDDAGTDIAAVAAGRISVTPIHFDLTSHAGLEPLRGY----------    
100 UniRef50_B2RH81        5'-nucleotidase surE n=2 Ta...   261     2e-68  1  36.9%   3:246   8:254     --ILVSNDDGFRAQGIRELAEALRPLGNVTIVAPDGPRSGASAAITSTLPIKlhREEGYTVYSCTGTPVDCVKLAMNTVFKekPDLLVTGVNHGNNAGICVIYSGTVGAAMEGCVCDVPALAVSLDDHsdMSHATAYAVHVSRMILKNGLPQDTMLSMNVPK---GKPLGLKPCAVTDGRFVDEYMASEDARGNAVYWMTGRQINKGTIEG-DLELMHAGYVTLSPIKLNMTSRRYLPVLEELLKR-------    
101 UniRef50_Q390V3        5'-nucleotidase surE 1 n=23...   260     4e-68  1  34.8%   2:245  10:259     -RVLLTNDDGIDAPGLDVLEQVATQLaeVWIVAPAEDQSGTSHSLSLHEPLRVHRKGDRR-FAVRGTPGDCVAIAISHLMKdrPDIVLSGVNRGGNLGTETVFSGTVGAAMTSMLVGVPAIALSQAFTDrwDTALALAPDVIRRLVAAGWDSDACLNVNFPPRPAQDVRGLKVTNQGAGTLQgeIVSGRDPRDIEYHWLKLARAPRDDDADSETVALGEGYVAVTPLKFERTHDQALARLRTSLG--------    
102 UniRef50_Q1MQB1        5'-nucleotidase surE n=1 Ta...   260     4e-68  1  35.1%   1:242   1:247     MNILLTNDDGIHASGLRAIYNELVKLGhvFPFAPTVERSGASNSVSLNVPLTTQDvgDFKGTAINGTPVDCVKVGLAKLHENPPDLIISGINAGHNVGTDILYSGTVAAAMEGCVAGIPSIAFSRPREepTQSYAEHAANLLKKIDFSLVPKGQILNINYPSISIKKTLGIKVCAMSTQGWEHKLHKKKDDNGKPYWFISPYIPYSHGISQTDVFFLLEGWITITPLMFNMTAQTTLSNLEQ-----------    
103 UniRef50_C9LFQ8        5'/3'-nucleotidase SurE n=1...   260     5e-68  1  32.1%   3:242   9:254     --ILISNDDGFFAKGINFLIDTLKDEADIIVVAPDSARSGYALAITSMLPVQAEMLKDEevYACTGTPGDCIKLALNRLVERKPDLVISGINHGDNSSVNSHYSGTMGATCEGALQGIPALAFSLCDHRdfQPLKTYILDFYRKALVWRFPPFTCLNINFPKV--DKFAGVRICRMARSRWINEIEdeRNGYSAKYYWLSGSRQSLEPeeDTDIWALSHDYVAVTPTTMDNTAYDFVELLRQ-----------    
104 UniRef50_C3XH30        Stationary phase survival p...   260     5e-68  1  35.0%   1:243   1:278     MkiFLTNDDGYFSQGLIALRNALSDIARVVVVAPAHEKSACGHGLCVSKPLQLIELEKDFYKLDDGSPTDCVYVGLCELfhTKPDLLISGINIGANLGEDTTYSGTVAGAMEGALHGIQSIAISQcaNRDFTLALDTIRQLSFDILHNNYTIGhlLNINIPAISKDECKGIKATQLGYRIYNSKAQVMQNPRGQKYHWIGLNPLQWQERDnsDFDAVANNYISITPMQLDMTDYACMQSLHSY----------    
105 UniRef50_B6YRQ5        5'-nucleotidase n=1 Tax=Can...   260     5e-68  1  33.3%   3:242   9:253     --VFITNDDGIYAKGLNELIKGFRKIGEIVVVAPEGARSGMSGAITSLNPVRirKEEDLTIYSCSGTPVDCVKLGVNSIVSRKPDLLVAGINHGSNAAVCVIYSGTIGATLEGCIIGIPSMGVSLTDHsdFSQAVKYGKLVAEKVLLEGLPKGICLNLNVPSI--SDVKGLKICTQTKGNWQEKIEKLKDPYDRVIYWLGGEFANEE-PENtdEWALSKGYAALVPLQVDMTAHYFYELWKK-----------    
106 UniRef50_C8WX33        Stationary-phase survival p...   259     6e-68  1  31.2%   1:240   8:254     MRMLICNDDGIQAAGLFALVEVASTFGEVIVAAPDRQRSASSHGISLHRTIRVERREVPgaFALSGTPVDCCKWALAVLHAERpdLVLSGINAGANLATDVLYSGTVAIAGEAALQGVKALALSHVGPpdFASAQEACRLLIELAIELDLPADTFLSANIPFVGRKTWTriVWCDLGVRRYHDIFSRELDVEGHEVYRYGGDIIDEAGEGLVDIGVVRSGKISLTPLRYHFTNDQFLHDM-------------    
107 UniRef50_B5Y821        5'/3'-nucleotidase SurE n=1...   258     1e-67  1  36.9%   2:242   3:250     -KILVANDDGIFAEGINILVTHLLKWgeITVVAPDRTKNATSHSLTLDSILRLRKvgYEGYTVVDGSPADCVLVALNDLVPDT-DLVIAGINHGTNCGIDVLYSGTVGAASEGVVNGKPSIAISSESPehLEITAQVLISLLDQGLLNATSSDWVLNINVPALKLEEIKGVAWATMSRHGWTNRVQRREDPRGQIYYWVTGERSKPEQSNNGDYQLLSQGFVTLTPVGLDLTDHESLKELSS-----------    
108 UniRef50_C1I8T3        Stationary-phase survival p...   257     3e-67  1  34.6%   1:246   1:251     MKILITNDDGINARGIIALAKEISKKHEIIVVAPREQKSASSHSISINNPIKIRedENFKAYSLVGTPADCTQAGLS-LLGGDIDIVISGINRGLNCGTDILYSGTVSAAVEGAIYSVPSIAISMdeDEDYSKAAKWISKILDVAEKGYLKENVVLNVNVPNINEEDIKGLKVCRLGKSTYKTNYILVEENEDKVYVTKGTRNDILED--DSDLYFLSQGYVTLTPLHFDFTNFKILDEVKDIFED-------    
109 UniRef50_B6IS03        5'/3'-nucleotidase SurE n=1...   253     4e-66  1  34.8%   2:234  11:249     -RVLLTNDDGIDAPGMAALARVAQELAevWIVAPEHDQSGMSRAISLHDPLRLLGKGERR-YAVTGTPGDSVIVGLREVLatPPDIVISGINRGANLGQEVAYSGTVSAALTAKLLGVPGIAFSQAFRdrWHTAMAMIPRVFEVLDGLGGLPEAVLNVNFPDVEPEEVTGFAFTRQAqnIVAIDTERRTDTRGIDYRWLSFRRAASEQPEDSDIAALRRCAVSLTPLGFDFTDT-------------------    
110 UniRef50_A6LS61        5'-nucleotidase surE n=14 T...   251     1e-65  1  33.1%   1:245   1:252     MNILITNDDGINAPGIIALAKEISKEHKVTIVAPKDQKSASSHSISIHSPIKIKEelDCKAYSVSGTPADCTQVGLS-FLKENIELVISGINKGPNVGTDILYSGTVSAAIEGTIYGIPSIAVSMddDEDYSKAVKWAIKVLDIAKEEYLKSDVVLNLNIPNFNERDIKGIKVCKIGRSTYKTEYILLESNEEGDLYTTKGTRNAIKEEE-SDLYYLYQGYVTLTPLHFDFTDFAILSDVTKIFE--------    
111 UniRef50_A1B5M1        5'-nucleotidase surE n=43 T...   251     2e-65  1  32.9%   1:246   1:263     MRILITNDDGINAPGLETLEAIATeaGEVWTVAPAFEQSGVAHCISYVHPTLIAELGPRRFAA-EGTPADCVLAAIADVmdNPPDLVLSGVNRGNNSGENVMYSGTVGGAMEAALQGLPAIALSQYmdDPFQAARMHGPRLIRQLLDYGDWTSdfYNINFPPCDAGSVKGTRVAPQGRRQGVreVEPYHAPNGRRFLWVLGGSQTAEATPESDVDANMRDYISLTPMRPDLTCHKTLAELRGVLEE-------    
112 UniRef50_O27484        5'-nucleotidase surE n=5 Ta...   250     2e-65  1  34.6%   1:243   1:253     MKILITNDDGVNSSGIIAARRAVEDLGETIIVAPATQQSGIGHALTLFEPVRVSEvdGSGAYAVSGTHTDAVIIGIFELMDEKPDLVISGINMGENLgsELTTSGTIGAAMEAAVHGVPSLAVSLQVRrdFSLAAELTGRVASRILRRGLPEGvfLNLNVPSHPASD--EIRITRLGDRMYNVHIKKRLDPRGRPYYWIDGDPA------GTDFRVQMSTHLRltPPPSPPYHSTAQQALTQW----------    
113 UniRef50_C0ZGV3        5'-nucleotidase surE n=1 Ta...   250     2e-65  1  31.0%   1:252   1:263     MRILVTNDDGIDALGIKRLVEALLTlaEVSIVAPVEEKSGVGHGITYRSALSPEQRdpVKAWAVNGNPADCVKAAYHLLFekKPDIVFSGINVGTNLGRDIYYSGTCSGAREAVILGVPGVALSYDNwdNYGDVVEMIRPLVKEFSDRalASEVFWNINIPHVPLAEVKGMVPATLSMNHYEDKYSEEAEG----YYLAREYPQVMPLAEPLDYDLLKHGYIAITPVHIDATDRTLLKQMDNWALLKAWGKQ-    
114 UniRef50_A0L4K6        5'-nucleotidase surE n=1 Ta...   249     8e-65  1  35.4%   1:243   1:245     MLILLTNDDGIASPGLQALKDALKERHDVVTLAPVKDMSGTAHAISRGEDIKLTRIAEYEV-AINGTPTDCVMAGLRMVLRRPPDLLVSGINMGANVAEDLSYSATAGAAWEGALSGIPSMAVSLCGSahFESAIKVTHMVIRQWLENPLPPGTFLNVNVPNVPEYELKNPKPTRQGLRF--NWPPPPVTAAGNPAFwtIPTPREEEFQLATDEEALRDGFTSVTALHCLFRHPHATERLKAW----------    
115 UniRef50_Q04Q98        5'-nucleotidase surE n=6 Ta...   248     1e-64  1  33.9%   1:245   1:246     MNILITNDDGIASSGIKALEAVLQKEHDTFLIAPLRERSATSMALSIYDSMRVERINDNH-YIVDGYPADCVNIGLHGDIFPRIDLVLSGINRGVNMGHDIHYSGTVGAARHGAVHSRLSLAVSSGntKDYDYiaEFVRHFIDE-YSSLLKVGVVYNMNIPFDFVSSMENLRITRLGKRTYEDTYSKKNIIGGIADFYLGGSKLEHATEEGTDFTAFFSGKISLTPLSLDQTDISLVQELSDTLS--------    
116 UniRef50_Q53W92        5'-nucleotidase surE n=8 Ta...   248     2e-64  1  36.6%   1:238   1:238     MRILVTNDDGIYSPGLWALAEAASQFGEVFVAAPDTEQSAAGHAITIAHPVRAYPHPSppAYRVRGTPADCVALGLH--LFGPVDLVLSGVNLGSNLGHEIWHSGTVAAAKQGYLFGLSAAAFSVPLNGEvdFAGLRPWLLRTLETLLRLERPFLVNVNLPLRP----KGFLWTRQSVRAYEGVVIPGEDPMGRPFYWFAPRPL-KEAEEGTDRWAVAQGFVSATPLRLDLTDETRLQ---------------    
117 UniRef50_A9GFF6        5'-nucleotidase surE n=1 Ta...   247     2e-64  1  43.3%   1:233   1:238     MriLLSNDDGYSAPGLTAVRDELARHADVVVCAPAVNQSATSHSLSLHRVLRLLEAA-PGVFAVDGTPADCIYVALHavLPRRPDLVVSGMNHGLNLGADIFYSGTVAAAREGALRGVPSIALSADAGASLPAAAALGVKLALALhqEGRRPAPLLNVNIPAGSSW---PVRATRMGARLYTEEVIFRRDPRGHEYLWIGGAGVRHDLVPGSDTEAYDAGAVSVTPLTLDLFA--------------------    
118 UniRef50_C7G5W8        Acid phosphatase SurE n=1 T...   246     6e-64  1  35.3%   1:224   1:229     MRILVVNDDGIKAPGIKRLVQMAAGLGEVWVVAPAAQCSAMSHRITVRGDLEVKPYdgVTAYSVGGTPADCVKVALGCLMTEKPDIVFSGINAGYNVGRDILYSGTIGAAMEALCWGVPAIAFSVAEEDECEVLNTYLEPVAKELISKTLPQNEIWNVNFPGCTLEEYKGILWDRiqNQYYRDNYKRTDRPDGSCIFSAAGLP-ETEAADGTDAGAVLSNYISI-----------------------------    
119 UniRef50_D1BMX3        Stationary-phase survival p...   245     1e-63  1  30.8%   1:247   1:253     MHILMCNDDGILADGLRHLASYLSQYYRITVVAPANEQSAKSHALTTEVPLKLdeDENPRLYALTGTPSDCMKFGLSYLldDMPDLVISGINHGFNLGSDVLYSGTVSAAMESGFYGIPGLALSVERyeRGDEMYPFIHELIKKIYVAGQFSG-LLNVNFPLRGTCDWDHFKMVSQGLQTYSNIIEARINSRGQDYYWLAGELDYGAESVPTDVEFARKGYITGVALTWKQQCDTDMKRVQNILDEI------    
120 UniRef50_C9M508        5'/3'-nucleotidase SurE n=1...   243     3e-63  1  37.1%   5:241   3:248     ----VTNDDGISAPGLDVLVRAFQAEGEtsVVAPSRQRSLCGHSMTLGRPVRLEPVdgVRSWQCDGTPTDCVILAFDGLGLSD-GTVFSGINDGANLGDDVTYSGTVAAAMEACLTGRQAVAVSVVTpvHYETAGAVAVAVFRQLRKSPLPGGVFLNVNVPDCPKDELAGIKICHQGQrrYGGMIRRHEENETGVSFWLEGRPHDEPQ-PGCELWAIGRRCAAVTPLGLKFTHGAALEQLR------------    
121 UniRef50_A9NG37        Predicted acid phosphatase ...   242     6e-63  1  35.8%   1:240   1:240     MNILVVNDDGIDAEGLHILTKAASYHGSVYVSAPKVQQSAKSASITYTGYIEVEEIEpvRTIVVDGTPADCVRLGV-KVFEQEFDLVVSGINDGVNLAIDVQYSGTVAAAFEASIMGLNAIAFSAPdpYIFDETIKLLDEIIEN---KLYLETDILNINYPHASFKKVLGTRITKMGLRIQHSEFIKTDKPN---TYRILGSNIFVKEDEDADMTAFNEGYVSITPLKMDRTDYKKIEKL-------------    
122 UniRef50_B3T8G7        Putative Survival protein S...   242     8e-63  1  34.5%   1:249   1:266     MKILVINDDGITAPGIWAAARALRQVGEVVVVAPDRQQSGVGASLTLHAPIKADPWspVSAFSVEGTPGDSCILALETLVKD-VNLVVSGINAGSNVGWDVMVSGTVGGGLQGFIRGINTIAISVatNTKYDIAEKILKPLAEKFKDYSG-DTLFLNVNIPKIEMSQVAGVRVTRMGGRSWGENV-RAENVGPEKRYWISRNKSISDTppDSDIAALKNNCISITPLRLGLGNDSAMPALESLLGDIPQ----    
123 UniRef50_Q1J2E1        5'-nucleotidase surE n=7 Ta...   241     2e-62  1  40.7%   2:247  11:261     -RILVANDDGIFSPGIKALALALADVGDVVVVAPDVEQSAVGHGITIRRPLRFKhfGTLPAYRVDGTPADCVVLGVHLL--GRPDLVVSGINLGSNLGDDLTHSGTVAAAIEGLALGLPSIAFSQQGNgsFTAGAAYAARLARAVLAKGLPPRVLLNVNFPAGLP---RGVRITKVGEHRWEDSIITRHDPEGREYHWVAGQSRAADadPDTDYGAVQAGYVSVTPVRLDLTARDLLGELAGYVPEI------    
124 UniRef50_Q1QD10        5'-nucleotidase surE n=1 Ta...   241     2e-62  1  38.1%   1:244   1:268     MKILMSNDDGVYAPGLLALYEALSTMAEVMVVAPNSEQSGCASALSITTPLYTHQL-PSGFIAVNGTPADCIYLALNEIydTDFDCVITGINSGANLGQDVLFSGTFGAALTAQLFGIPAIATSLVgeRHYQMAAS---EIVKLLTDTPILDIcvLNVNIPDVsaDEINGRKMTVLGHRKIARPVHHVVDPRGRDAYWLSLRKRqsSGTTMTDDQAVAAGYISLSPVRLHHTPAATLDMLSALM---------    
125 UniRef50_B9E0C7        5'-nucleotidase surE n=2 Ta...   239     6e-62  1  33.3%   1:246   1:244     MRLLLTNDDGIMAEGIQVLAKHFEKDNEVIIAAPDVQRSGSGHCItvPGELIIQEVknSKAYSITGTPADCARLGVRKLGNNQIDMVISGINNGFNLGIDSLYSGTVSAAIEAAICETPSIAVSLdgNYDYNIAAEYALEVFSIYKdkNKDENVVLSLNVPCLPREKIKGLKVCRVGFKYHLQEIYDK------------GEKTEELSYNYTDIYYVKRGYAALSPLHYDLTNYKILGDINNLFTE-------    
126 UniRef50_D1VSZ7        5'/3'-nucleotidase SurE n=1...   238     9e-62  1  31.0%   1:245   1:249     MNILVTNDDGIMAEGIRTLAKVLIDKGhvTIAAPNVENSGKSHAITFKTPLVVQNIegVKAYSVFGTPADCVRAAVH-LCDKKFDYCFSGINSGYNAATNVLYSGTVSSAIEANLFNIKSVAVSAsgQVNYQSAAKIAMELFDKIKDENILQ--VYNLNVPFLNYDEIKGIKVAKVGKDVMS---IYDISSEGNEylKLKGFPKEFNGDKDSDIYYLNQGYATVSPLYYDTTNKTSIDHLKEILD--------    
127 UniRef50_C9RKP8        Stationary-phase survival p...   238     9e-62  1  30.6%   2:246   8:267     -RVLITNDDGVGSVNLHALALALSEVSDVYVFAPEDEQSGVGHAFTIRRGLRVQHVepYEVYSVSGTPADCVKFAVGhiVPEGFDVCFSGVNVGENSGVSSLYSGTVAGAREAALWGVPAVALSLRggNLLQVAIDFARKIVSENLFKKISKGVFWNVNFPKIKEDEFLGFKACTMDRGMFTDHYDHK-----DGLWFLDGEKLWSMAPEGSDDNLLDKGYATITPHRIDQTDEESLEVISEMLGS-------    
128 UniRef50_B3CLR5        5'-nucleotidase surE n=9 Ta...   238     2e-61  1  28.9%   1:242   1:239     MIILITNDDGFESEGIRLLKEIAQNFaeVWIVAPDADRSGAARSLDYpqFIKISQHSERE-FSVSGTPADCVIIALNKIMNKKPDLILSGVNIGSNVGDDICYSGTIGAAMEGAARSIPSIALSQVYHddWNNTKIFAPKVIAKLMKVGWPKDIVMSINFP--ATEKVKGVEFAEQGEYNIDGDLTFTENLNGS----LSLNWSREHSGSGS-VDKIKGGFITITPIKLDFTDYDILNAMKN-----------    
129 UniRef50_C0FND5        Putative uncharacterized pr...   237     2e-61  1  33.2%   2:224  36:263     -KILITNDDGIQSDGIIRLARAAKKYGKVWVVAPDGQRSAMSHRITLHETIEffPVEGVHAYASTGTPADCVRFGILNIVKEKPDYVFSGINYGYNSGTDIQYSATVGSALEAACAGVHAVAFSEGASECHEVTDAYLERMMEELMEQPLAYNQIWNVNFPQCELEKLRGikIADCG--FFIDEYLEEELENGRIRLTVHGNYNE-NAPEGTDFRALVDGYISV-----------------------------    
130 UniRef50_C6XFK1        Stationary phase survival p...   237     3e-61  1  28.6%   1:245   1:249     MRILLTNDDGIKSKGLITLENIARSISdiWICAPEMDQSCLANSLTMSRNIACRTISKKR-FAVHGTPVDCVVIALQKMSDKKPDLILSGVNVGTNTSNHVAYSGTLAAAFEGSLQGIRSFALSQAYtiPWEVSETHAPRVLRQLLKTQIPNTTLCNINFPRCSPEEVQKTVVTAQGKPCFSIDAKQISTNDNMSHYCLTFGDHLKNLCEKSDAFAIQHNMISVTPITTDLTDYNSQQYISLSLE--------    
131 UniRef50_Q3YSH3        5'-nucleotidase surE n=5 Ta...   237     3e-61  1  30.4%   1:240   1:247     MKVLLTNDDGFHATGIKVLKEIIIESgeVWIAAPASNCSGYGRSIGVKTATDVYQIGDTE-FIVNSTPSTSAFLGLREITGKKPDLVLSGINSGINVGNDIGYSGTIGAAAEGAMMNIPSIAISQegEINWINPQKFLKKIINMLLEVPFwkSTIMNVNFPLVPA---KGIKFTSQGEYIPSNKIEKKRNVSGSISYTVHRIAPDKGNRGYSdiKAIDDGYITITPLKLDMTDFDALESL-------------    
132 UniRef50_B1L691        Stationary-phase survival p...   235     2e-60  1  32.8%   3:231   5:253     --ILLTNDDGIHSAPFRALWIAlaKIGKVTVVVPEHEMSAAGKGITLHKPLRIRkfGYREAFTVSGTPGDAVTVALKFIMNSTPDIVVSGINVGDNITLDNltSGTIAAALQASIMGIKSSAFSVEIpdRFLTHARIAAKITDWILRRGMPEGvlLNVNFPYRVSQD-TPIRITRLARAKYENYVLERIDTRGNPYYWLGGNppVTEKDRGTDLYALteRAISITPITLEM----------------------    
133 UniRef50_Q0F8M6        Survival protein SurE n=1 T...   232     8e-60  1  30.9%   1:243   1:251     MKILITNDDGIDAPGLAVLYKilTSAEKILTVAPATEQSGVSHAISYHSSINLEKITKNR-WACHGTPADCVIVGISE-YNQKFDLVLSGVNRGNNAGQNTMYSGTVGATIEAAMNGIPAIALslDNENIFDAVSMHGLKTIQNIlwNNNSAPIHYNVNFPPCLGIDVTGTSFTMQGYRTGAP---FSTETSNELLKIKGLPQQQEDTGSGTDINANINGKISITPCSVDLTNHAVLRELLKL----------    
134 UniRef50_A6G4W5        Stationary-phase survival p...   231     2e-59  1  42.4%  31:247   3:215     ------------------------------VCAPTSERSGFSHAITLRSSLRSEPAPEFgwYAVSGTPVDCVYLAALHLCERPPDLVLSGINPGYNLGADVFYSGTVGAAREGLIRGSSALAVSVEPGGAPQLAAPFVRTLVPMLLERSAteRHLLNLNVPCEAHG---GLRVTRLGHRRYEDKVDERQDPSGRPYFWIGGPPAEHDAGATEDLGAVAEGFAAITPLELDITA----PEIDDWARAL------    
135 UniRef50_A3MT21        5'-nucleotidase / 3'-nucleo...   231     2e-59  1  31.2%   1:231   1:239     MRILVTNDDGVYSPGLRLLYQFAEPLGEVDAVAPETPKSASGLGITLHKPLRMYEMdgFKVVATSGTPSDTVYLALYGL-GRKYDLVLSGINLGDNTSLqvLSSGTLGAAFQAALLGIPAVAYSLYAES-WdeALHVLRAVvrYVAERGMPQGvvISVNFPQRPRRGVR-AKLAKPAKLRYAQRVEARRDPRGAAYFWLYGEPLS--PEPETDVYVvkEGNVAVTPLALNL----------------------    
136 UniRef50_C7GZ44        5'/3'-nucleotidase SurE n=1...   230     5e-59  1  34.7%   7:242   3:245     ------NDDGINAKGLRALADEISTIADVYVVAPDGERSAMGHCISCRDKIYLESQDFPgaYKCSGTPADCVKLGIDFlmDIEMDFVVTGINHGGNLGTDTHYSGTVSAALEGVMNKVSSIAVSVVSHEafDYPAKLAKdvLGRF--GSIPNDRMLNINVPDKPEAEIKGIKFTKLGRRGYVDIFKRLPDENGKFCYTYSGNPRHYGTCDDedVPAFEMGYVTVTPMGLDFTDHEMLSDINK-----------    
137 UniRef50_D2EF06        Stationary-phase survival p...   228     1e-58  1  26.8%   1:246   1:259     MVVLITNDDGYKTEGLHTLYRAAKKvsEVMVVSPDKLQSSSGMSFTFHKPLRVEKikGMPCYTVSGTPADCVFMSIYHLFKNKVSMVLSGINEGMNAGLETVysGTISAAMFAAISEVPSIAFSKNLSVdmKSSYESVVKILENIKTKKFPRNimININLP-LKINKKTEIKIVKTDKRVFDDIVIKKKDPNGKDYYWLYGT-LRKDLDKDADLYNLFNQKITVTPIKLSTTEELHIKTLKDIFHN-------    
138 UniRef50_A6F5B1        Stationary-phase survival p...   228     2e-58  1  30.8%   2:238  14:251     -RILITNDDGINAPGLAILERIARNLAevWVVAPEHDRSGAGQSISIHDPLRVYENGEKR-YAVSGTPADCVLYSLAHWfeNPPDLVLSGVNCGANISDSVQYSGTVGAVLSAEHMGIPAIALSQaeGVDWSPVSVFGEQVIRKLWQPG--ENRAWNVNFPACDAGVIRQAQWCNQSTgiQQPRLLAGQDARSLPYWWLGFDRSSRhtAPDEDVTVLREKAIAITPLR----HREALP---------------    
139 UniRef50_Q08W51        5'-nucleotidase SurE n=1 Ta...   227     3e-58  1  28.2%   1:248   1:261     MRILLCNDDGFLAEGLRTLASELTQHGhvTIVAPSAERSGQSHAMTFFEPLLVRHVSHQ-VYAVHGTPADSAFIGLRGVLGkpPDLFIAGINHGLNVGIDVNYSGTIGAATEASLLGFRAMAISMDVDpaFQRTARLAAELIGHLHRLDWAPQEMLSLNHPGHEPRGLVAAHCHPDCIYVPheHLASRTHSREdqVYVIGGTTRATPQDGEHDVAALQAGYATLSFLQTHQGHTPGTSRLRPFLDMLR-----    
140 UniRef50_D2LKR1        Stationary-phase survival p...   226     7e-58  1  35.1%  41:245  12:223     ----------------------------------------AAHSLTLHEPLRLRKLSERT-FAVKGTPTDCVIMGVRHVLTDkpDLVLSGVNRGSNVADDVTYSGTIAGAIEGTLLGIPSIAMSLadRIYWQTPMQLGADLVRKMLDAGWPKDVFLNVNFPDREPERVECIKITEQGRRDPdlRIEDRMDTRNNPYYWLGFKPMSMITGEGTDLHAVKSGAISVTPLCLNLTHRETCRKLSAFIE--------    
141 UniRef50_UPI000038E0AE acid phosphatase SurE n=1 T...   225     1e-57  1  29.5%   3:229   2:239     --ILVTNDDGFNAAGIKQLYKNASMVDDAVMVAPDSMRSASGMSITFTRPMRIQSLegINGYCVSGYPADTITVAQNIIlgKKIDLVASGINIGSNISLRSIysGTISAAIAAALKGIKSIAFSMVTdpDFSKAGMYSRYIIEEFKKSGFPEndILNINFPAQITDE-TEIKVVPMAENVFHDYLEHNVDPNGKDYYWL-GNTVEKTQDRNTDYYVleENNISVTPLSV------------------------    
142 UniRef50_Q6KZ11        5'-nucleotidase surE n=1 Ta...   222     1e-56  1  28.7%   3:253   2:244     --ILVTNDDGYNSYGIRVLYRAAASIAESYIVAPDHGRSATGMSTTYNVPLRAFKFDYG--YAISGFPADSVYMARYALydKKIDLIVSGINHGDNISLRSLysGTIGATMAGALIGIKGIAFSMssNEKIDLAEPYIKAIIENAMERFPDDVDILNVNFPGNLNRN-TRILPARMSYNIFDDNIIKRLDPNGHEYYWFGNKRHER-CPENCDYDVvrKNSISITPIT-----------VKGYLDDLRSTEEF    
143 UniRef50_Q2JLL2        Acid phosphatase SurE n=13 ...   219     6e-56  1  31.9%   1:229   1:237     MKVLLTNDDGIEAAGLANLKLALSAleHCWIVAPHQPISGCSHQVTTGRPFRALARGERT-FAVEGSPADCVRVALFKLA-PAVDWVLSGINEGGNLGSDVYLSGTVAAVREAAMRGIPGIAISQyqPIDWEQAQRWTREILAELMEQSLPRGAFWNVNLPHLPAGSPLPERvcPLCTQPLPLDYAVEAEGNGAESLWFrgRYAERARDPQTDTDICFSGRVAITQVQL------------------------    
144 UniRef50_D1HYN3        Whole genome shotgun sequen...   217     3e-55  1  30.3%   2:229  12:280     -KIMVTNDDGIDAPGLRALVQVltNLYEVLVCAPDSEKSAVSHSITWIHALAVKRVegATAYAVSGTPADSASLGIStlFPSIPDLVISGINMGSNCGYHIVYSGTVAGAREAFLNGIPSVSVSYNWVadFKLAAEACLPMISAVlnQRYPERCFLNIDLPTDVVNH-KGYKLTKQGKSRVkpEVCTEMdprgEHLLFKREVRGAPVLEDDTDYQCLLEGYITVTPLGA------------------------    
145 UniRef50_A9WCM3        Stationary-phase survival p...   216     5e-55  1  36.4%   1:228   1:244     MHILVTNDDGIDSPGLWALAKAMRAAgrVSVVAPAEEQSAMSMALptNRELRAieLDGMLAFAHNGSPVGCVTVAMLSGVLPPIDAVVAGINRGLNGGSNVMLSGTVGAAMIGALWGLPAMAVSLQypMPWATAAYVAERLFPLLEQIRGQAPLVLNVNVPHVapDDLRGFRQTRLSEFFFGHYLDIELNPTgsQIIFRFARERVPDFDVDTDDGAVRAGYVSITPLR-------------------------    
146 UniRef50_A2BLQ8        5'-nucleotidase surE n=6 Ta...   216     7e-55  1  29.3%   2:230   6:245     -KILVTNDDGIHSPGLRLLYEAVKELGRVYVLAPETPKSASGLGITLHKPLRIGKvgDTMVYITNGTPSDVIYIAIEE-FSPRFDVVVSGVNIGDNTSIQvlSSGTIGAAAQAALLGIPGIAFSAddRETWENMKRVIRAITSWVLEHGMPEGvlISVNFPRKVRKDTK-VKIAPAARIKFLQKVSVLYDPRGRKYYWLYGTLV--EPEPGSDVYVVheKAIAITPLSLN-----------------------    
147 UniRef50_C9LM69        5'/3'-nucleotidase SurE n=1...   216     7e-55  1  30.9%   1:243   1:251     MHIFVTNDDGVAAPGIRALARALSALAKITVIAPAEGVSSCSSALSLRKPMKLKKreNIEVYSLTGTTGDCCKLALEYWLKDdpDLIVSGINDGFNTGSDCLYSGTVAGALEGIFAGIPSMAVSMESMAdlRETAAFAADLVsyFMKKRY--TGILNVNIPKIKPEkwENVKVARLGLLRYSNVIAGKRTKADEMEFIMRGKPLER-YEPETDVYWSRKGYITITPLQWNQTDFENLREVGKL----------    
148 UniRef50_Q3KME4        5'-nucleotidase surE n=11 T...   215     9e-55  1  28.9%   1:246   7:268     LRILITNDDGIKAKGISLLISLLREaaDLYIVAPLEEQSGRSMAFSLVEPTTLEPFDYpeAWAVTGTPVDCVKLAIGELFKENadLILSGINNGKNSGRCLYYSATVGAIREANLHGIPAIALSQSENIAfaHMASLIRSLCEFTVAYKHTDPLGLNVNFPASTDDswKGIRFTLSGNEFLFGIPRLVRTEGNRRYYTLYDMRDKVSEEFSEEYLALANNYISAAPLVSKNTPRATLSelKDSFEQ-------    
149 UniRef50_Q114P0        5'-nucleotidase / 3'-nucleo...   215     1e-54  1  30.8%   4:224   6:226     ---LITNDDGIDAPGIRALHKALSQVtrIVMVAPKHHQSGCGHQVNIRTVIPVEWRSETEV-SVDSTPADCVRLGVNYLYDD-INFVVSGVNSGCNMGSDIYPSGTIAAAREATIHRIPAIAFShdWEIDWERAIQWTVMVLKKLLAEPPEEGTLWTVNFPHLEPDAPEpmVFCRLCNRPLLTEFVKKENG-----YLYVGYDLNRKSDPGTDVDVCLSGNIAI-----------------------------    
150 UniRef50_D2RQ51        Stationary-phase survival p...   215     1e-54  1  32.0%   1:247   5:262     LEILLTNDDGIDSTGIRALYDALSELGNVTVVAPATDQSACGRSMSHEVDVDDRELG----YAVHGTPSDCVVAGLAEL-GPFPDIVVAGCNEGANLGEYVlrSGTISAAVEAAFFDVPAIATSMyhPEDFAEATRVTSYLVENALEAgfDHAAYLNVNVP-LADGDPAPLEVTRPSKRYEMDAERDGGRVHLKDRVWERMDPETLPDPDGTDRRAVVEGRISVSPLTAPHsrHEGLSALADAYSET------    
151 UniRef50_Q8YSE9        Putative 5'-nucleotidase al...   213     4e-54  1  31.4%   1:229   1:226     MTIILTNDDGIDAPGIKALAQAVSGK-NFIVAAPRDHQSGCGHQVTTTRPINLQRRSDSE-YAIAGTPADCIRIAITQI-SQDVKFVLSGINAGGNLGVDAYISGTVAAVREAAMHGIAGVAISHyqNFDWELAAKWTAEVLEELLHRPLEPGYFWNVNLPHLQPGETQplVFCQPCTKPLPANY--RID--GDDFYYVGEYGK-RERTPGSDVDVCFTGNIAITQLRV------------------------    
152 UniRef50_D2RQN3        Stationary-phase survival p...   213     5e-54  1  37.0%   2:247   8:277     -HVLLTNDDGIDAPGIRALYDALTEVATVTVVAPDRNRSAVGRSLSYGRtlEADGFTSPvgYAVDGTPCDCAIVGVNAL-EPRPDLVVSGCNSGANLGAYVFssGTVSAAMEAAFLGTPSIAVSMDtpADFAHTGEITAALVEGAPGTGldRVDYLNVNVPR-PDVESEGVELTRPTEVYEMDAALENGEFQLTNRLWQQMANRDIPDPEDTDRHALLEGAVSVSPMRVP-YDVVDTDAVRTILEDV------    
153 UniRef50_Q7XB62        Os07g0204500 protein n=5 Ta...   213     5e-54  1  33.5%   3:229  17:286     --VLVTNDDGIDAPGLRFLVGQLVAayRVLVCAPDTDRSGVSHSITWRPALRCKRVdgATAFAASGTPADCASLGISGKLFdvPDLAISGINVGNNCGCHVIYSGTVGGAREAFLYGIPSLAMSYDWVadLKVAAEVVMPLINNVMAetYPQGSFLNIDIPTDAAHH-KGYKITKQGRYmwEQTVYKktSSENDLLFKRVLVRRSYDEEEGDDIdcLVDGYITVTPLGA------------------------    
154 UniRef50_P73440        Putative 5'-nucleotidase al...   213     6e-54  1  29.3%   1:229   1:225     MNFLLTNDDGIDAPGIEALYEALGKRG-VWV-APKNQHSGCGHKVTTDQAIAVEQRGKNR-YAVDGTPADCTRLGVVHFYPE-VDWVIAGINAGGNMGIDSYLSGTVAAVREAAILGHKAIAISHWINknWAWASHWANAVFNTLWQQDLPPQHFWNVNLPHWQSGDPEpvIFCEPSR----DPLPVAFTIEGSNFFY-RGEYSQRPRQPGSDIDVCFSGNIAITQLRV------------------------    
155 UniRef50_Q823A7        5'-nucleotidase surE 2 n=1 ...   211     2e-53  1  27.9%   1:229  12:252     LKILLTNDDGIFAPGMTLLVSNLLKaaDLYIVAPKTEQSAKSMAMTFHEPVILQPYDYpgAWSVSGTPVDCVRIALAYLFKDepDLVLSGINRGSNAGRHVFYSGTLGAAIESTLCGVPAVALSQEGnkNFDIPEMLKSLSLYALSLPFAPHPVALNVNFPAS-NERWKGMRFVTTGPEYSCGVPHFLFCDGDSKIFKLSGGPKIVEEIPSEEWQTLRASYIAVSPVMA------------------------    
156 UniRef50_UPI0001C418A6 5''-nucleotidase SurE2 n=1 ...   209     1e-52  1  32.2%   2:243   3:260     -NILISNDDGVMGPGILASKQALEGLANVVVVAPQENNSAVGRKVNIMKHMYLENYegSMAYGLSGTPADSVNVGINYVCDEVPDLVVTGINPGINISrqITTSGTVCAAIEAVGLGIPAIACSlyVDTDYSFAQKILAKLVKKVLDEGMPDGvlFNLNIPSKPLSD--KIKITRLADSMLKFNILERVDDDGNDTV-MNVPELIEDYEEGTDGYCLleRRPSLTPLNVHFGA--EISNLEDW----------    
157 UniRef50_A2R7M7        Contig An16c0150, complete ...   208     1e-52  1  24.8%   1:238   1:324     MHILVVNDDGpsSPYIHSFVQSLQSAGhvSVVLPHQQRSWIGKAhtYFRPGTLHkyDGDEWILVDSTPASCVQIGLYHYFQDriDLVVSGPNYGRntALFALSSGTIGGAMEAAVCGKPAIALSYasSRDHDpaSRHSVRLIEYLHKNWADGVDLYTVNVPLEPGVSQNKVLYTNMLDNRWsqHKHFEWAPNFSDVY-----RSVEEGAPGNDGWAVKEGMTSVTPLRANFMHTPGIQ---------------    
158 UniRef50_Q9Z8S6        5'-nucleotidase surE n=2 Ta...   208     2e-52  1  30.4%   1:227   8:245     LKIILTNDDGITAKGMSCLVSALLEagDIYIAAPQAEQSGKSMAISLNQVVCASPYAYpeAWAVGGSPTDCVRLGLRTLFEssPDLVISGINCGNNICKNAWYSGTIGAAKQALVDGIPSMALSQDNHISfdKAPEILKALVIYLLSQPFPCLTGLNINFPTSPGgsWEGMRLVPPGDEFFYEEPQYLGSVNKNQYYVGKISGVRIGEHPSEELACMLENHISVSPI--------------------------    
159 UniRef50_UPI00016C49EF stationary phase survival p...   206     6e-52  1  30.1%   1:229   1:227     MKLLLTNDDGIEAAGLHALLTAARGLGEPVVVAPAGPQSGVSHAVTTEGPVRVDARDNR--FAVHGTPADCARVGLHRLCPDA-GLVLSGINHGGNLGADVYYSGTVAAVREAVLHGWTGVALSHYRKrdWPRAARWAARCLTDLLARPRVPGAFYNVNLPHLRPDEPDpmVFCPLDPHPLPLSYRHEGDG-GMRY---DGDYHTRQRTAGADVDVCFGGRIAVTVIKL------------------------    
160 UniRef50_B8DSE4        Stationary-phase survival p...   204     2e-51  1  31.4%   2:246   5:265     -RILLTNDDGVHSPGLLAAAEALHPLGGVDVFAPLRQQTAMGRAQTGDRNAILQQVepLRAWACDASPAATVGHGLKVMPGYAPALLVSGINYGENLGASITSSGTVGAALEGACRGIPALAVSmyTEQDWSAAMHFLALFAGMVLERGLpdVHVLKIDVPAGATPD-TPWRLTRLSPDMYYEsaVPSLGSrgDATVTKGPAPGES---PETDVYALsdRVVSVTPLTLDFTARTAFGDIRAWLDG-------    
161 UniRef50_A8IGE2        Predicted protein (Fragment...   203     4e-51  1  32.5%   2:229   5:270     -RILISNDDGINAPGIKALVAELVKaaDVYVCAPSGERSAQSHAITLGRYLSCVPTEPTTayAVDGTPADSVMLALCSPVFQdfDLMISGINRGDNAGLHVIYSGTVGAAREAACKGIPAMALSLDNhdDYAVSASLAValPGQEAGGRApkGVVINVNFPIAQGQMLQGLFLARQSLACVFPAFKEVTEAPgsRVFRNYAGMVQEDQEEGNDAYALKNGWVAVTPLSL------------------------    
162 UniRef50_A8MBQ3        5'-nucleotidase surE n=1 Ta...   203     5e-51  1  32.6%   1:227   1:244     MRILVTNDDGLTSMGIVTLANELAKEHEVHVVAPETQLSSIGAARTYNRPIRIWRwgPVDVYATDGTPSDAVFMGINM---FKPEIVVSGVNLGENVGLESLfsGTIGAVIQSSLIGVPGIAASIEVPPhfSGIVKVIKGIINHIEAEGWVKGvaLSLNMPSPSRWSGGYVVVSRMAKRLFKETVIESSDPRGNKIYWRWGEEL-MPLDTDTDAYAfrEGKLTVTPL--------------------------    
163 UniRef50_Q2GE33        Acid phosphatase SurE n=2 T...   202     1e-50  1  28.6%   1:245   1:252     MRALITNDDGFDSPGLTLLREFVLSIgeAITVAPKTNRTASSHAVSLDKKLRIEEIAEN-VFSVDGTPADCVITAFHDSRLTkpDVVFSGVNIGANLGIDTIYSGTIAAAMQGMLSGTVSFAFSQFYSSSPHtsPHIKKYILSMLEKVDILKNCVLNINIPEC---QVIGVKHVPQypNKRKSAIRARPHEEDNEKYITIEGTSSPQFCE-----FLRSGYVTVTPVGCDLTHYAALKFLDSSFS--------    
164 UniRef50_C8SKF5        Stationary-phase survival p...   201     1e-50  1  28.9%   1:253   1:241     MRILICNDDGIEAPGLARLVNAVTGLSdvWVVAPDGKRTAAGSSLTIARPLTMRRVKPN-WYSCSGTPADCVVSAMTWLfeKKPDLVLSGVNDGRNVAEDLAYSGTLGIAREATFWGVPAIGFSRVKNPDfdGDDHWLGTLIASLWqdWTSEGHWLSVNLPTSLPAEIRQPRIGRDKIGRTAEILESDAD----RTVITVPRGRAHASEPGDENAAIDAGFVSINRL--------------NWFGETRLDERF    
165 UniRef50_A6RRE8        Putative uncharacterized pr...   196     4e-49  1  24.7%   1:243   1:317     MHILVVNDDGpsSPYVHSLVQTLQAAGhvSVVLPHTQRSWIGKAhtYFRPGTLHEDDGteWVLVDGTPASCVQIGLYHYFKDrvDLVVSGPNYGRntAVFSLSSGTIGGAMEAAVCKRKAIALSFAFfrNHDpaSRIGVKIIEYLYNNWGEGVDLYTVNVPLVEGVEKNKILWTNMLQNYWGehKHFKWAPRFTDVY-----KSVEEAEPGNDGWAVKEGYtiVRPIQLPQASYTLLSSPSDL----------    
166 UniRef50_A7BP97        Acid phosphatase n=1 Tax=Be...   194     2e-48  1  61.0%  86:244   1:163     -------------------------------------------------------------------------------------MVVSGINAGPNLGDDVIYSGTVAAAMEGRFLGLPAMAVSITspHYYQTAALVVESLLARLQNdpLPADSILNVNVPDLPLEKLKGMRVTRLGSRHRAEPAIKSEDPQGSPIYWVGLAGPEQDAGPGTDFDAINQGFVSITPLQVDLTRHSALEKLEEWL---------    
167 UniRef50_A1RWH2        Exopolyphosphatase / 3'-nuc...   193     3e-48  1  29.6%   1:250   1:251     MRILVVNDDGVG-DGLLALARVAERLGhvFLATTHDQRSGYSKSVSFKATYTPAKIGGYEGIVTNSSPASAVLLA-FKVFGKEFDFVLSGVNMGPNLgwDILSSGTVGAVLEAALHGVPGAAVSLvtYEDYERAARLAVDLLERL--EWRPPCEVLNINVPLRTNGS---VKFT-LPERVPPRDLYRCSGNECRMGYW-TLQESYVCSNPRSDVCAIKEGFVSVTPLSPGSLAREDL--VKKLTRSTSLG---    
168 UniRef50_D1S4A6        Survival protein SurE n=1 T...   191     1e-47  1  35.5%   2:229   8:263     -RVLVTNDDGVHAPGIRALARSAYERgdVVVAAPEAEASGMSAALsvFRETELDGLPGVPAYAVAASPAYIAVLAGLGVFGPVPDLLLSGINRGANAGHAVLHSGTVGAALTAGNNGIRALAVSldESRHWSTAADLAATLLPWLA--GADPGTVLNLNVPDRPADQVAGL---RQATLAPFGQVQVSVAERGEGFVRTAVEANAVRAVPGTDIAWLADGYAAVTAIRA------------------------    
169 UniRef50_B4WKJ7        5'/3'-nucleotidase SurE n=1...   190     3e-47  1  32.0%   5:223   6:224     ----LTNDDGIGAPGILALQKAVEPLGQTVVVAPDTHLSGCSHQLNRGGAIAIDQRSQTE-YAIGGTPADCSRVAISHLY-PTADWVLSGINAGGNLGSDTYVSGTVAAIREAALLRKPGIAISQYRYrdWPRATRLARKVIRQLMEKPTQPGEFWNINLPAPPldDEPDVIFCNQCTQPLPTEFA--IDETGFRY--IGAYEKRL-RDRGGDVEVCFSGQIS------------------------------    
170 UniRef50_Q18F17        5'-nucleotidase surE n=6 Ta...   190     3e-47  1  31.8%   3:247   7:265     --VLLTNDDGIDAVGIQALYQAFDDIAEVTVVAPTDDQSAVGRQLSSDVTIH----EHDWGYGIDGTPADCVVAGVEALC-PDVDLVIAGCNKGANIGAYVlrSGTVSAAVESTFFDVPAMAVSMYIpsAFADASRAATYLARHAFDAgfEQADYLNINAP-VAANEPATLEVTRPSRVY---DMTAEHDGNghDRVWERMRTDDIPDPSGTDRRAVVDGHISVSPLAAPHthHEALDAlsTYLDSI------    
171 UniRef50_A5DPP1        Putative uncharacterized pr...   190     3e-47  1  23.9%   1:238   1:288     MHILLTNDDGptCPYIKYLVDEINTATDwsIVIPNQQRSWIGKAHFAGRTLSTTYidYQEWCLIDSTPAACADIGIHHMYETPIDLVVSGPNFGKNSSnyILTSGTVGAAMEAVTHGVKSIALSYAFNsdykEAAKISVKLIEKLYHQlqPQVDLFSVNIPLVESLKltRIHYAPILQNSWNSIYAPNVDDNGrqFLwpDFKKVYKDGLLdtDSRVLLNEGISVTPLRAAFTVTHPLE---------------    
172 UniRef50_B6H3Y3        Pc13g10510 protein n=17 Tax...   190     4e-47  1  25.1%   1:231   1:314     MHILVTNDDGpsSPYVHSLVHSLQSAGhvSVILPHQQRSWIGKAhtYFRPGTLHqdEGDEWVLIDSTPASCVQIGLYHYFKEriDVIVSGPNYGRNtaLFALSSGTIGAAMEGACCGKRSIALSYasSRNHDpaAGHSVKLIEHLCANWADGVHLYSVNVPLEPGVSENKVLYTNMLQNTwgNSEKSSSGPrhKHFKWadVYRSVEESEPGNDGWTVKEQMTSVTPLKANF----------------------    
173 UniRef50_B9KI89        5'-nucleotidase surE n=4 Ta...   190     4e-47  1  28.5%   1:239   1:256     MRVLLTNDDGFDSVGMRVLRDVVSgfAEVWVSAPARDCSAASRALSVRTPIKTHMRGERE-FVVHGTPADSAVIGICEMtgKRPDLVISGINYGANTGFTVPYSGTIAAAAAAFDIGVPAIAISQQYntSWQNSRKSVMALVSRLLRDTMWhkCIMSINVP---YSDVQGVKfcDDGHIKWDGPSMERRegDGRCvyVFDDMRSPNSNDNASDTQLLEQGYIVVTPIGHSMTDHATLDK--------------    
174 UniRef50_Q0RTZ1        Acid phosphatase SurE, surv...   189     6e-47  1  34.8%   1:247   4:283     LHILLTNDDGwdTPLIVALRDALKAAGhvVVVAPGTDQSGQGGRISAPpqLTVARPEPSVWTVTPGSPSDSVFFAFDQVfnAKPDLVVSGINPGNNLGQAVNHSGTVNAAATALEFGVPAIAVSLQTSSTwkSSAAYVADLVARLEGRsmPPGVGLNVNYPLLAGppPRGVRPTTLDTGVALDlyTPTSGQAGQptYTIGLTPNDQAAPAGTDTRAVQDGYVSLTPLEAD---RDVDGSTESWLHRI------    
175 UniRef50_A8BAE8        Acid phosphatase surE n=2 T...   189     9e-47  1  30.6%   1:248  19:296     MRILLTNDDGHNFIGLTTLRQIMLDSGhvIVAAPAHDQSGKSQSLHYIKELNVSRV--AHGYVIEGSPVDCVRLGLQ--LHPDVELVVAGINNGANCGSDVCHSGTVGACFEAANMGYHAISYSMDTrsNCKEPVQTTLDaiSYLAQNGSKRqmVWNVNIPA-PHVPVLGCKAAVLGHRYYSVKYAYsiDLLNSSSSWTMRGELDPDSLpeADFDAVEKGWVTVTPLNPDRFHTDEYDSVLRVLSNLG-----    
176 UniRef50_A9HDS9        Predicted acid phosphatase ...   189     1e-46  1  30.9%   1:246   1:247     MRILIANDDGIDAPGIALAEEAARKLSdvWVVAPEAKRTAAGSSLTVGRPLFMTETAPQR-FSCSGTPADCVVTAMTWVFKdkPDLVLSGINDGPNVAEDIAYSGTLGIAREATFWGIPAIGMSRVKNPQltDDTDYLARLIGRLwqHWVLYGHWLSINLPAALPAQLRQARIGRDKIASTSD-VISQNGARTELLVPRGRMGTGKDGDEN---DLLGQGHATLTRLSW-LGHRTVDDAVMSALTG-------    
177 UniRef50_B5JGB2        Survival protein SurE n=1 T...   189     1e-46  1  25.9%   2:229   3:249     -KILIVNDDGIDSPLLLALVSSFQRLGEVVVAAPRYEQSWVGKCMSRFKDVDVIERkpCEAYSISGSPADCVNLALGHLLHEKPLCVVSGINVGHNAgaYILSSGTVGAALEGALHDIPSFAASLGLDrdYdlAATLLTDFAEKTMVSGEPSyvVHKLNFPFAPIDKDTPIVRSNPA-RTEAGSFFTQT---GNAYSFTYRELAENAPAVPTDRDTLKAGHISYSRLDF------------------------    
178 UniRef50_D1Z3R6        Whole genome shotgun sequen...   186     6e-46  1  26.0%   1:235   1:338     MHILVVNDDGpsSPYVHSLVRELQAAGHVvvCLPHTQRSWIGKAHMIGQTVKPLYYRPpeWILVDGTPASCVQIGLYHFFQDriDLVVSGPNYGRNtaVFALSSGTLGGALEAAVCKRRAIALSYafNRNHDpaSRQSVRVIEALWKEWPTDrdLYSVNVPLLEGLEEGKVLYTPMLQNYwhTHKHFKWSPRFTDVY-----KSVEEAAPGNDGWAVKEGHTSVTPLKANFWNTA------------------    
179 UniRef50_B2GIE3        5'-nucleotidase SurE n=2 Ta...   185     1e-45  1  31.0%   1:229   9:245     MHILVTNDDGISSPGLAVLARAALERGhvKVAAPAEEYSGASASLslVPASPPEMPEDVECVGVKAAPALIAFLASYGAFGQRPDMILSGVNLGANTGKATLHSGTVGAVLTGASHGIPGIAVSigAPQHWDTALLVTRYALERWEQRPFDE-WILNVNVPDVSPDRLRGLKPARLASFGAVQAQIGRGDEKHIAVTYSAETGPE---EPESDHYLLTHGWATATLLRA------------------------    
180 UniRef50_UPI000197BC91 acid phosphatase n=1 Tax=Pr...   185     1e-45  1  33.3%   1:225  25:270     MRILLVNDDGCDAFGITELKSQLDAKgdVWLVGPATNQSGIGTAITfgKEFDVKKVDERT-YCFPGTPADSLDFGLQGLLRepPDLVISGVNDGPNTGTSQLNSGTVSAAARAVRLGYPAIAASIgtHKYWPDSVTYVVELVDDLNKNwlPAKSGLSINYPALAKDKIKGIKFVE-NEYAVSPQILYEITPEGKAKQIINPEALKIRND-DSDTGYLDKGYITYT----------------------------    
181 UniRef50_A2RAR0        Contig An18c0130, complete ...   184     2e-45  1  25.6%   1:238   1:317     MHILVVNDDGplSPYIEPLVTALESAGhiSVAIPAASRSWIGKAHLIEASLTATYvdNDWVIITNGTPASCVQLGLHNLFPDriDLVISGPNHGRNASTIYNLsgTVGGALEAATCGKRGIAISFGSKDeiHAAARLATRVVNHLIQNWDDQVELYNVNVPMRLDVESRPVLWTRTYPYYWARGYLYSehANgrNFAWAamKKALQESPEGTDAHTVLSGCTSVTALRANFWHVPGLE---------------    
182 UniRef50_UPI0001746631 stationary phase survival p...   184     2e-45  1  29.7%   1:229   3:237     LHFLLTNDDGIEAPGLAALAAAVSAiaTYTIAAPDREYSQCGHRVTTTEVLKVLQKAE-HAYAVSGTPADCVRAAVFGL-GIKPDFVLSGVNAGGNMGQDLVISGTVAGAREAAYHGFRSAAFSHYLVkdWERTGRWTTQLIEWLLGQNLADGEFWNVNYPHLPPGslPERLITSPARPPMLVTYDRSEGNAGEWDLRYTARYADRPAPVGSDVNVCFGGAVSVSRLSV------------------------    
183 UniRef50_Q84MD7        At1g72880 n=11 Tax=Embryoph...   184     3e-45  1  30.5%   3:245  63:378     --VLVTNGDGIDSPGLVSLVEAleGLYNVHVCAPQTDKSASAHSTTPGETIAVskLKGATAFEVSGTPVDCISLGLSGALfsKPILVISGINQGSSCGHQMFYSGAVAGGREALISGVPSLSISLNweSHFKDAVGVCLPliRDIAKGVFPKDCSLNIEIPTSPSSN-KGFKVTKqaNRHPggNFMSNQQSLGAQLAQLGRDASAAGAaeHTdvKALEDGFVSVTPFslPKTDSETQAAASEWIS--------    
184 UniRef50_Q6CC87        YALI0C11495p n=1 Tax=Yarrow...   184     3e-45  1  24.6%   1:240   1:312     MHVLLTNDDGpySPYFHYLVKAIEKYthVTVVLPDTQRSWIGKAHMIGQTITATYIEAPewTLLNGTPATCTNIGLNYMIDepVDLVISGPNFGRNtaLYSTTSGTIGAAMEGALCGSKGIALSYAYYSrvAEASRLAVKLISKLYENWDKGVDLYSINVPLIEgsDNTKAVHAPILQNRWKGTFEppIEPDSEPlyTMFRWAPDFEasPGNDGWVVDQGHISVTGLKASFSETGITGEI-------------    
185 UniRef50_A4R2M8        Putative uncharacterized pr...   184     3e-45  1  27.2%   1:232   1:329     MHILVVNDDGpsSPYVHTLVRALQGAGhvSVCLPHTQRSWIGKAHLIGQTVRPTYYRPpeWVLVDGTPASCVQIGLHHMFTdkVDLVLSGPNYGRntALFALSSGTLGGALEGAACKVPSIALSYAFfrNHDpaSRHAVRVVEALVKQWPQdvDLYSVNIPLVEGVEKARTLWTPMLQNYWAdeERIRQGAGGEAALSSGAQNGKAAAdpGNDGWAVKEGYTSVTPLKANFW---------------------    
186 UniRef50_C1MYI8        Predicted protein n=1 Tax=M...   183     5e-45  1  37.6%   3:231  15:315     --VLVVNDDGIDAPGILALVRALANCgdVYVAAPDAERSACSHCISIHAPLAVEPRSIPGayAVSGTPADCAMLATGALFPsrFDFVVSGVNRGDNLGRHVIYSGTVAGAREGAMkgGVGVAVSLCSYsdYSDAASVAAETLTAVRStgALAGKVLNVNVPhgGGSGIKGVKLTRPGFSCTQPDWVRVSSPggGDAAWTKggPHTRDDGDGTDQRAIDDGYVSVSILSCEF----------------------    
187 UniRef50_D1I2X1        Whole genome shotgun sequen...   183     5e-45  1  31.7%   3:182  44:238     --VLVTNGDGIESPGLTSLVQAlePRFHVHVCAPQSDKSVSGHSMTVQETLTaaEIGGATAYEVSGTPADCVSLALSGALFskPVLVICGINKGSSYGLNMFHSGAVAGAREALLCGVPALCISMNWKedFKDAVNVCLPiiRDIEKGIFPKSCLVNIEIPSSPLKN-KGFKVARQSLRRPA-----------------------------------------------------------------------    
188 UniRef50_C1EEU3        Predicted protein n=1 Tax=M...   183     5e-45  1  35.0%   2:215  17:241     -NVLVVNDDGIAAAGLAKVVEALDRTgdVYVVAPDKEMSATSHSISIHNAVSATPrgATRAFSSSGTPADCTMLGLSVLYrkRFDYIVSGINRGDNLGLHVVYSGTVAGAREGAMrgAVGVAVSLDSYsdYSEAARLTAELVTSIHDAPglRGCVLNVNVPNLPRTHIKGVKLTTPGLSCTQAEWVRVPGTRGDSC---DDLNEDETRGPDSDSD--------------------------------------    
189 UniRef50_B0NGY9        Putative uncharacterized pr...   182     1e-44  1  25.1%   1:231   1:253     MkiLITNDDGIHSPGLAAAACAAADLADILIVAPHTQQTGMARAFPRTEDAGIIEEeeVRGYGVHGSPALAVAHGVLELAERKPDLCISGVNYGENMGAVLTCSGTLGAAFEAVSHGIPTIAISLEAetDWDAAKRMLHSWISRVLDRGMPEYvlININMPA-GSGHPDEFRITSLSRQNYFEFIRPKARNLKEPFALKSRLSVDMDteRDSDIHAVYVDRisVTPINMNM----------------------    
190 UniRef50_O83434        5'-nucleotidase surE n=2 Ta...   181     1e-44  1  40.9%   1:159   1:167     MRILLTNDDGYQAAGIRALHAALKAayEVTVVAPDRDRSAVSHGITTLEPVTVKEVE-PGIWSCSGTPVDCVNRALRQVcgTPPDVVVSGINEGENLGTDIVFSGTVAAARQAVMYGIAGIAASLLPVSdfQALARFVARHVRALAALS-SEDVLVNIN----------------------------------------------------------------------------------------------    
191 UniRef50_C6H1G0        Tubulin-tyrosine ligase n=1...   181     3e-44  1  22.9%   3:233 443:759     --IRVVNDDGpsSPYVHPLVHTLESAGHVvvVLPHRQRSWIGKAhtYFRPGTLHKDDgnEWILIDSTPASCVQIGLFHYFKDriDLVISGPNYGRntAVFALSSGTLGGALEAAVCGYRSIALSYasSRDHDpaSRHSVRLIGHLYKNWEEDVDFYSINVPLEAGVSEAKILYTNVLDNRwhRHMHFKWAPKFSDVY-----KSVDLGPPGNDGWTVKEGMTSVTRLKANFMH--------------------    
192 UniRef50_B9LSF3        Stationary-phase survival p...   179     6e-44  1  35.3%   3:220   5:260     --ILLTNDDGIDAVGIRALADALSRDYDVTVVAPASNQSGVGGARSWWDT-TVEYTETDAGYAVEGTPADCVAVA-DVALGLDPDVVVSGCNHGPNIGAHIlqSGTVGAAMEASFLGTPAIAVSLydNGDFAVAGEVVVDLLDRAETgsLpgADVLNVNVPAADDEAAAdyRLTEPARGFDVIEFHPGEapEgrDRFWREFLRGDVADDPGSDRLAAVEG---------------------------------    
193 UniRef50_C9SJ06        TTL domain-containing prote...   179     1e-43  1  26.4%   1:231   1:270     MHILIVNDDGpsSPYFAPFLAALHAAGHtvVVIPDRPLSWIAKAHPVGKTLTATPYLPmhWLLVDGPPASCVQLGLFHTggSAFDLVISGPNHGRNSGahTLSSGTVGGALEAALCGRRAIALSFGSkrRTADACLRSCALVEELAREWAPGVELYSVNVPMVDSVTTCPARYTKVAANRWSkpEESQEDAKGTLRFRWAPDLADVHRsaGEDLWCSLNESISVTPLKADF----------------------    
194 UniRef50_A6DQJ4        Predicted acid phosphatase ...   178     2e-43  1  23.7%   1:224   1:243     MKILVTNDDSQDSPLLEYLLDELKGLGDLQIVVPKEEQSWTGKSISRFEQleEIEISGVKTCVLSGRPADCVNFGVYHMGDEKPDLVISGINIGYNCGvyVMSSGTVGACIEANIAGVPAVSLSreTYQRWSNERCFSPEEIKQirADFLAEPITWQVEMPQDLSEDWS-LEAGHLGHSFYGSLFEQKSNG----AYGHSLKKHDLDSREKADVNIIARGNVSV-----------------------------    
195 UniRef50_C1G129        TTL domain-containing prote...   177     3e-43  1  24.9%   1:181 417:639     MHILVVNDDGpsSPYVHSLVHTLQSSGhvSVVLPHRQRSWIGKAhtYFRPGTLHKDDgdEWILIDSTPASCVQIGLFHYFKDriDLVISGPNYGRNtaVFALSSGTIGGAMEAAMCGLKAIALSFasSRDHDpaSRHSVRLIGYVYENWGEDVDLYSINVPLEPGVSEGKVLYTDILQNRW------------------------------------------------------------------------    
196 UniRef50_B0CQ21        Predicted protein n=2 Tax=A...   177     4e-43  1  23.0%   3:241   5:312     --VLLTNDDGpeSPYVLGLYLHLTrlgnVHVVLPSTQKSWIGKaiTRGNYFYPKEDGKGewILLDGTPATCANVALHNIFHEKIDLVISGPNLGRNTSsfALSSGTIGAAMSSSLSKIRSIALSYGTVVhfEPAHNLACRIIQHLWNNWGEDEclYSVNIPLVesEEGLKICWTRMWRNSYGRLFKNISTVNQDSiyTTSMPKNEGEepFGSDGWAIHNGWVSVTPLRASFGEPHIHDDID------------    
197 UniRef50_Q0JJY1        Os01g0709400 protein n=6 Ta...   177     4e-43  1  29.5%   3:195  68:275     --VLLTCAGGIRAPGLAALVDSLVAGgdVHVCAPESDKPACGYSITIRETITATSVdgAKAFEISGTPVDCVSLALSGRLFsaPALVISGINAGANCGYEMFHSSAIAAAREALLYDVPSIAISLNWksDFKDAAEVCLPLieGVEKGTFLRGCLLNIGVPSSPTTN-KGFKLTKQSIYRPAQSWEGVSTSRPTP----------------------------------------------------------    
198 UniRef50_C6WQS9        Survival protein SurE n=1 T...   176     4e-43  1  29.8%   1:228   1:233     MRALVTNDDGIDSPGLLALARGAREHgeVVVAAPEREASGTSAGLTahRSIHVERRdgFEAYAVAGHPGLIALVASRGGFGEVPDVVLSGVNRGANTGRAVLHSGTVGAVLTASVNDLRGMAVSLDVPLewDSAVTVARGLFDVLA--GLPDGAVLNVNAPNVA-DPGEPVRAT-LAEFGSVQTRVKRADEGTIDV---NSVLVPGDLPEGSDAALLVAGRATVTPLR-------------------------    
199 UniRef50_D2Q361        Stationary-phase survival p...   175     1e-42  1  37.0%   1:227   4:232     LRVLITNDDGYQARGIRALATAIAAAGhvLVVAPLDDQSGVGSArlVDRPIRTTEETEDGITyvDGTPALAVTLARAGAFGPSPDVVASGINHGHNIGVPILHSGTVAAALTAATQGLSAIAVSLDspKHLDTAALVAARALDWLATE--PAGTVITVNVPDRPLDELEGVRRATLAP-IERSRITGGTAPTGEPM--IRLEPPAAAPSPDTDEALLAAGYVTVTPL--------------------------    
200 UniRef50_B1ZS95        Stationary-phase survival p...   175     1e-42  1  30.0%   1:227   1:265     MRLLVTNDDGINSVFLHELVHALQAAGHVliAAPKREQSWVGAGKSRHRAVHCELVddCPTWIVDGTPSDCVNIALAHLldASPDlvVSGINVGLNASlfILASGTIAGAWEGALHGLPAVAFSQDMSTalKISARHAAALTPQLlaTPLRSFTVHNINFP-VAIRPDSEVRRTVPARVIVPGLFSPAADDGTHTFVFSHGEEMSVE-DALTDRAAVAAGYISHTTL--------------------------    
201 UniRef50_D1BXY9        Survival protein SurE n=1 T...   175     1e-42  1  31.1%   1:235   1:250     MLALITNDDGIASPGLVVLARVAQAAgdVVIAAPKAESSGASAALhlDGRLMVEPAEPprAFAVSADPALITFSAAYGAFGARPDLVLSGVNRGPNVGNAVLYSGTVGAALAATSLGIRAVAVSLddPVHWDTAEQVAAHALAWFATVDAGRRT-LNVNVPDLPPGELRGLRQAPLASFGAVHARVVPADprGDDVV-IRYEGTERHTEPESDAGMLDAGWATATLLVAPWADTT------------------    
202 UniRef50_C5DUD1        ZYRO0C15796p n=5 Tax=Saccha...   175     2e-42  1  23.3%   1:249   1:316     MRVLLTNDDGpfSPYVRPFVQHIRKNyeLTICIPHTQRSWIGKAHFAGKSLTAqsNDDIEWILIDGTPASCVNIGLHHLNSEPFDLVISGPNVGRNTSsyISSSGTVGAAMEAVISgtKAVALSFadSSVVDLAAQKSMEVINHLYHNWNDGTDLYTINVPLSTSLKptRIMWTSIWENRWRAIFE------GPDVAQLTNGSEIEDGVEgtDKDVIEAKMISVTPLRA------TFKKVEGLVGELSL----    
203 UniRef50_B8N162        Putative uncharacterized pr...   175     2e-42  1  24.3%  13:238  84:365     ------------SPYIRPFVNALQDAGhvSVAIPAASRSWIGKAHLIEASLKATYVPppEWVVinGTPASCVQLGLFNLFQDRpdLVISGPNHGRNAStyNLSSGTVGGALEAATCSKRAIAISFGSKDPQPdaARHAVKVVNYLYEHWHADVELYNLNVPMREDVESRPVRWTEALPYYWpgEVTADKKVNGhdFTWAamKKTLQSSREGTDAHTVLNGDTSVTALRANFWHVPDLE---------------    
204 UniRef50_Q8ZSY4        5'-nucleotidase surE2 n=5 T...   174     3e-42  1  28.1%   1:217   1:212     MKIVVTNDDGPHSPLLEPLVRGLEAVGnvVVVVPERPRSAAGLARTYHKPLRVRRLGG--YYVVNGFPADAVFLAL-KLIAPDAELVISGVNVGENIGIEATysGTVGAALQAGVLGVPSIAASMEVGGDVDFMIKVVEGAVAS-ARAGLDGVLAVSINIPSVWKGGVYCVR--KLARAVYRERLYEGVDPRGEKYYWRWG-PRRSEFEPDTDAYYF------------------------------------    
205 UniRef50_Q18E70        Acid phosphatase n=2 Tax=Ha...   173     4e-42  1  31.7%   3:229   8:263     --ILLTNDDGIDAPGLATLRTELTALGNVTVVAPESNQSGVGRTRNPTAIVR----DHPWGCALTGTPADCVAYGLRGL-DTNIDIVVAGVNNGPNAGNYVvrSGTVGAGIEAAFLGTPALAISAYHStdFARPARIARRLVDRALSAgyDDVDLLNVNAPVDTAN--PPVMLTDPYHDYEQEVEQASADdqLRDRTWPGVVGWESPFPpgTDRRALVDAAVSVSPLSV------------------------    
206 UniRef50_C7Z590        Putative uncharacterized pr...   171     2e-41  1  25.1%   1:235   1:288     MHVLVTNDDGpaSPYVSCLIQQLKGAGH--TVSPLYYrsSVIHgtTHHRPSPSGDVE--EWILIDGTPASCVQIGLHHFFQDriDLVVSGPNYGRNtaVFALSSGTLGAALEAAVCQKKAIALSFAFFTriEAACRRSVKVIEALYKQWPTdaDLYSVNVPLVEGLENKKAIWTNMLQNYWRehKHFKWAPRFTDVY-----KSVEESKPGNDGWAVKEGLTSVTALKANFMHDS------------------    
207 UniRef50_A3IZH6        Glycerophosphodiester phosp...   171     2e-41  1  29.1%   1:227 306:556     LEILLVNDDGFEAEGINVLFEGLKAAgdVTLVAPKEQQSGRGTLINVDkpTEVVNFEPNKWF-VDGSPIVTTLAGLDYILDEEPDLVISGINEGANIGEnvISSGTVSAATTATRRGIPSIAVSAGGNtaYEEGTALIIDIIETLEAQRLPEAEllNINIPGTFAEGVNGIQGVVLTELDEISNLEFSFGeeGAGVLviTPSEVENEMSEGENFLA---GFMTITPI--------------------------    
208 UniRef50_P38254        TTL domain-containing prote...   170     4e-41  1  20.2%   1:252   1:325     MRVLITNDDGpfSPYIRPFIQHIKRNykITVCVPHVQKSWVGKAHLAGKNLTAqpKDTIEWILIDGTPASCANIGLHLLSNEPFDLVLSGPNVGRNTsaYITSSGTVGGAMESVITgtKAIAISWasPLLMEKASKRSLDVIKHLVKNWDPKTDLYSINIPLVEssDDTKVYYAPIWENRweNSFAEIEDGNEssFNwiHYMDEYKDRTVLTDAEVIESEMISVTPMKA------TFKGVNHLLGELKLTEE-    
209 UniRef50_C5JQM9        Acid phosphatase n=4 Tax=On...   168     1e-40  1  25.2%   1:238   1:343     MHILVVNDDGpcSPYLFPFVKTLEKAGhvSVVIPNSSRSWIGKAHIIGETLEATYISppWVVVNNGTPAACTQLGIYSLFPDriDLVISGPNHGRNAS--IIysGTVGGALEAATCGKKAIALSFASKEkiQAASRLSVKLIERLSAHWPDERvlFSINVPMRLDVEERPAVYTNMLPNSwgGDDDQRIPPQQARYFKWAPELSdeASKVGTDTYTVMNGWTSVTPLAANFSHVSGFS---------------    
210 UniRef50_C4Y1P2        Putative uncharacterized pr...   168     1e-40  1  22.5%   1:231   1:275     MHVLLTNDDGPPspFMKPFVDEIRRSTnvSVVVPNQQRSWIGKAHFAGKKVAANYieYQEWVLLDSTPAACADIGLHHvhSEPVDLVVSGPNFGKNSGryILASGTVGAAMEAVTHGTKAVALSYedPETVREACRVSVRLVARLYrqKQPDVDLFSVNVPLVPSLSltPVKYAPVLCNAWESMYSEewTPDFEQVWRDGLADKRH-----SDSRVLADDGISVTPLRAEF----------------------    
211 UniRef50_Q7UF93        Acid phosphatase SurE n=1 T...   167     2e-40  1  37.2%   3:166  14:204     --ILLTNDDGIDAPGLVAMHQAiqDRYDITVVAPDRGRSECGHSVTTTRDLAVTEVQS-GWFAVDGTPVDCVRSAMTVLCPNA-SLVFSGINAGANLGVDLLVSGTFAAAREAALHGVPSMAVSHYRRPdwDHTGRWLKPVLDSFFREVMspGQLWNVNLPAIDPD---------------------------------------------------------------------------------------    
212 UniRef50_Q9YDW8        5'-nucleotidase surE n=1 Ta...   167     3e-40  1  26.5%   1:245   2:256     LKAIVTNDDGVHSRSLRALAESLASRgdVVVAAPLGNWSGYSKSIGRFRGNRVYRFESRGVRFFTGDMPPAALVGTadIAGFEPDIVVSGINYGPNLgyDFFSSGTIGGALEAALRGFKSVSISSACREelPEALSISLAVVETSVETLSSSAGLMVVNIPRSP----RGFKVTRPCRRVP--RFSGEIGEEGSLLVEKFDHSRLFSSEHDsdGRLFSMGYIPVspL--DPSRDGYLKAVEDILN--------    
213 UniRef50_Q2GKI2        Stationary-phase survival p...   167     4e-40  1  28.6%  24:240  10:232     -----------------------QAFSEVWISAPARNCSGMSRSISVGVPVEARKVNDRE-YTISGTPVDSAVLGLhsVAGVLPDLVLSGINYGSNVGSKVLYSGTIAAAAAAASMGIPSIAISqgTDINWGNSEKVVLDIVKQLMDDpwDRKSVMSINVPHF---DILGMHFTEQGDYCPCGDVADAPGEEPdtIYTICDVNRETKLeqKASSEMLRAGYIIVTPVGSDLTDHSTLNRM-------------    
214 UniRef50_A4T4H1        Exopolyphosphatase / 5'-nuc...   167     4e-40  1  28.8%   4:246  10:259     ---LITNDDGIDSVGLHVLAGAAIKAgdVIVAAPAEqqDGR----TVVER-RELPDLDVEAWAVQAQPGHIVAAALNGWFDPRPDLVLSGINHGANVGRAILHSGTVGAALTAKISDTRALAVSLngERYWETAAGLIAPVLDLLLEA--PDGTVLSLNVPDRPADEVGPIRPARLAPGGAVQTKVEEVRDGG---VRLTEVEVPDKPDADTDSALLDAGHPTLTELRSVEADDGDL--VHRWLEG-------    
215 UniRef50_B9WFM4        Tubulin tyrosine ligase, pu...   166     8e-40  1  24.2%   1:231   1:290     MHVLLTNDDGpsCPYFKYLVDEIITTTDwsIVVPDQQRSWIGKAHFAGKTLSASYieYQEWCLINSTPAACADIGIHHLynKPVDLVISGPNFGKNSSnyILASGTVGAAMEAVTHGVKSIALSYAFnhDykEAAKISVKLIKKLYQQLQSSsdLFSINIPLVDSLNLESTKitPLLETNEKGQLQFSWTPDFKKVYKDGLADKNH-----TDSRVLLEEGISVTPLQAAF----------------------    
216 UniRef50_C3K8C6        Putative stationary-phase s...   162     6e-39  1  27.9%   1:226  21:280     LNILLSNDDGYQHPNIRALYTQLKAQGhvKIAAPQSDQSARGGAFFFGREVTVGHDTDPAyyYIsgTPVMALLMGLDKVL-PHPDLVIVGPNPGNNLGAINMASGTFNAASVALQSGIPALAVSTdkEQDPQRAAQLVAKLVDTLDRHrlPPGLGLNMNLPK--GTQIKGVKLTRVGSyrYSDDL-KQFNLPGKPGIGFQYSPAATAAQQNDEAVWLNKGYLTISP---------------------------    
217 UniRef50_O23348        Putative uncharacterized pr...   162     7e-39  1  32.1%   3:167  16:238     --IMVTNDDGIDAPGLRSLVRVltNLYDVRVCAPdrEKSAVSHSIIWSRPLTAKRVegATAYSVDGTPADCTGLGLSelFPSRPDLVLSGINVGSNCGYNmvYSGTVAGAREAFLYDVPSASISYDFdnDFALSAQACLPIINGIlnKTHPMQCFLNIDLPTDIANH--------------------------------------------------------------------------------------    
218 UniRef50_B4G027        Acid phosphatase n=9 Tax=Sp...   162     7e-39  1  28.9%   3:192  70:274     --VLLTCAGGIRSAGLAALVDALVAAgdVHVCAPESDKQACGHSITIRETIAASSVdgAKAFETSGTPVDCVSLALSGRLFpsPALVISGINTGSNCGYEMFHSSAIAAAREALVYGVPSIAISLNWksDFKDAAQACLPLINAALDdtFLRGCLLNIGVPSAPSAN-KGFKLTKQSGYSPAQSWEAVSTSR-------------------------------------------------------------    
219 UniRef50_Q4P3P7        Putative uncharacterized pr...   159     9e-38  1  26.0%   1:231  70:395     LKVLLVNDDGpsSPHVLGLYEELCALgeVSVVLPSFQKSWGSMQFSlrRPINRERGEIAEWILIDGSPTTASNAGlnAFFGDTpdLVVSGPNFGRNTGtfALSSGTVGAAMAASLAGVRSIAVSFgnPPTFatANKLSASLIQRLYDNWapDVGCYSINIPLCETISQPQVIWTRIWENRYGPLFAAEStpKPQNVLHFAPNMapTTLPEGTDVWAILNGYVSITRLRPNF----------------------    
220 UniRef50_C5GBJ4        Acid phosphatase n=1 Tax=Aj...   158     2e-37  1  24.5%   6:238  79:416     -----VNDDGpcSPYLFPFVKTLEKAGhvSVVIPNSSRSWIGKAHIIGETLEATYISppWVVVNNGTPAACTQLGIYSLFPDriDLVISGPNHGRNAS--IIysGTVGGALEAATCGKKAIALSFASKEkiQAASRLSVKLIERLSAHWPDERvlFSINVPMRLDVEERPAVYTNMLPNSwgGDDDQRIPPQLARYFKWAPELSdeASKVGTDTYTVMNGWTSVTPLAANFSHVSGFS---------------    
221 UniRef50_C9PGF2        Acid phosphatase stationary...   157     3e-37  1  26.9%   1:227  26:312     LNILLTNDDSWETTNIQVMKSTLEAAGhvIMSAPCTGQSGKGGAMTFLKPVSVDETQSADQEYceGTPVMAATYGIdaVWGQDPDLVISGPNEGNNLGYMNNNSGTLGAAMISLSRGIPAIAVSANSNTASDavANVVVKIVAQLVANqlPAYTGLNVNTPE-EMNSTMGYKFTDVGWNGGGALLKFSDDLSTDsyYTmgGMTSEedTSEDSEGIAVNEGYITISTI--------------------------    
222 UniRef50_B7H2T6        5'-nucleotidase surE(Nucleo...   157     3e-37  1  25.3%   1:245  21:313     LNILLVNDDGLTS-NIKALYDELKANGhvLVSVPCSPQSGRGGAIVMYSSTTItgYTNGDWNYTHGTPVMATVYGLDVVAPKrpDLVLSGPNEGQNVGKVVVHSGTIGNVQFSAGRGIPSIALSAdsNPNSAIVAKQTVVLLKELQAKalPKGITLNVNFPKNLTTS-TPFAFSKIGTYdyKLKFQVTKDNKGNNQFGLgaAPSAPTAAQMSDESAVMQSKIAVTAMQV---AYDQRPPAQEWLK--------    
223 UniRef50_A5DII9        Putative uncharacterized pr...   156     8e-37  1  21.4%   3:245  22:319     --ILLSNDDGWASTYIRAAYRDLKDAgnVILVAPVSQRSGYGGKFDVPtpSWDHEKDDQNIWYFNGTPASCISFALDYLLPEkpDLVVAGPNEGPNLSPGFYtsGTMGAVYNAIYRGIPAISFSGSDFNnfKDssKKVVELTKKVIDGGMPAITGINVNFPKvpSCDDPKWQFGrmGKGVFVQNMKYNSDSGLMEWGTKYFDNISKDCDSGddIYLKNNCSTSVSVFTVDytTLSTSNTVKKLLG--------    
224 UniRef50_B6QKV6        Acid phosphatase, putative ...   155     1e-36  1  24.6%  40:238 108:335     ---------------------------------------ASSEHLNVSTPDDQNENEEDYWAVinGTPASCAQLGLYELFPNriDLVISGPNHGRNAStyNLSSGTVGGALEAATCGKRGIALSFGSKDeiAAAARLSTRVIEHLWRNWDERVELYNLNVPMREDVESRPVRYTRALRNEWteIQQKGKSNRIRQFQWSTekRSLAESPQGTDARTVLDGFTSVTPLKANFWHPDGFS---------------    
225 UniRef50_C4R6Y8        Putative tubulin tyrosine l...   154     3e-36  1  23.0%   1:191   1:234     MHVLLINDDGpsSPYAKFLVDAIRNHTDwsIVVPSQQRSWIGKAHFAGKELTAQYLYsqEWVLIDGTPASCTDIGVHHLYKDKpdLVLSGPNYGRntALYIMASGTLGGALEGALTGKRAIGLSYSFyrDHDaaSELSLKLIKYLYNNWHPEAELYSINVpkDSLGPDTKAIFAPILENRWGSVFTKVIES--------------------------------------------------------------    
226 UniRef50_UPI0001908C8F stationary phase survival p...   152     9e-36  1  33.3%  97:252   1:160     ------------------------------------------------------------------------------------------------VADDVTYSGTIAGAIEGTMQGVRSFALSQAyyEdwEVCETHAPALLEKLMVLDLPEGTFLNLNFPNCRPDEVDGAEVTMQGKLAFNLQVDARSDGRGFPYYWLKFGERAGAFIEGTDIHALKHNKISVTPLKLDLTDYSVTDRVARAL---GYGAQ-    
227 UniRef50_A2R979        Similarity to hypothetical ...   152     1e-35  1  25.0%   1:188   1:236     MHILVVNDDGpgSPFVHSLVNELKAQGhvTVVLPNRQRSWIGKAHFVGEIVRPTYYYPDrwVLVNSTPAGCVQIGLYHShpNPVDLVISGPNLGANTTtfSLSSGTIGGALEAALCGKRSIALSFEPPSKLpeASRHSVRLINYLYHNWDEGVELYSINVPLQPATTAAGERKVMYSRIRPNRWLSES-----------------------------------------------------------------    
228 UniRef50_B5EV17        Acid phosphatase n=2 Tax=Ga...   150     4e-35  1  27.3%   1:227  25:312     LNIVLTNDDSWNTNNIQAMKSALIEQGhvIMSAPCTGQSGKGGAINFFKAVNVDTTQSAkeYCveGTPVMSVLYGIDVAAQErpDLVVSGPNEGNNLGYMNNNSGTLGATMIALSRNIPAIAVSGSENSAQDsiAKVVVDVINNLEKTrlPAYTGLNINTPHDIDNNL-GYLYTNVGWNAGGIELKFVSDLSNNEmyVVnmAGDAGDTDEMSEGVAVKSGYITISTI--------------------------    
229 UniRef50_Q9SSN8        F3N23.8 protein n=1 Tax=Ara...   150     4e-35  1  25.5%   3:245  63:352     --VLVTNGDGIDSPGLVSLVEalEGLYNVHVCAPQTDKSASAHSTTPGETIAVskLKGATAFEVSGTPVDCISLGLSGALfsKPILVISGINQGSSCGHQMKKNES--------------------QESHFKDAVGVCLPliRDIAKGVFPKDCSLNIEIPTSPSSN-KGFKVTKqaNRHPggNFMSNQQSLGAQLAQLGRDASAAGAaeHTdvKALEDGFVSVTPFslPKTDSETQAAASEWIS--------    
230 UniRef50_C9STC1        TTL domain-containing prote...   149     1e-34  1  28.8%   1:153   1:198     MHILVTNDDGpsSPYVASLVAELKKAGhvSVCLPHTQRSWIGKAHIIGQSVKPVYYTPseWVLVDGTPASCVQIGLHHFFAErvDLVVSGPNYGRNtaVFALSSGTLGGAMEGAICGKKAIALSYafSRNHDpaARHGVRVIEKLYADCPPTP----------------------------------------------------------------------------------------------------    
231 UniRef50_Q2UK26        Predicted acid phosphatase ...   146     7e-34  1  22.8%  46:238  11:236     ---------------------------------------------TLETTFPDTETQPEWVVIRNGTPASCVQLGLFNLFQDRpdLVISGPNHGRNAStyNLSSGTVGGALEAATCSKRAIAISFGSKDPQPdaARHAVKVVNYLYEHWHADVELYNLNVPMREDVESRPVRWTEALPYYWPrtADKKVNGHTEpfTWAamKKTLQSSREGTDAHTVLNGDTSVTALRANFWHVPDLE---------------    
232 UniRef50_C7BLP0        5'-nucleotidase SurE (Nucle...   146     7e-34  1  29.2%   1:168   1:173     MKIVIVNDDGYEEPFHHDFVDHLKKLadVISVTPSKNMSGFASAINIRNYVQFTEYESQM-YKVDGTSVDCALIglANYFWGKPDLLVSGINRGMNYGPCVIYSGTYAAARESSRQGILAVSFSANenRRILDSATL---ILEKILSDKFdkNAVLNVNFNSVLSDKL-------------------------------------------------------------------------------------    
233 UniRef50_C4YC48        Putative uncharacterized pr...   145     1e-33  1  27.9%   3:167  36:246     --ILLTNDDGWAATNIRAAYRDLKNAgnVVMVAPVSQRSGFGGQFNIPppSWGHEEDDLNIWYFNGTPASCVAFAVNYVFPttIDLVVAGPNEGTNLSPGMYtsGTIGATYSAVGRGIPGIAFSgnGNNSfdDVAryARKVVEMvhPNLLPLTTGINVNFPPTGDED--------------------------------------------------------------------------------------    
234 UniRef50_C5MD31        Putative uncharacterized pr...   144     3e-33  1  26.1%   2:177  21:244     -NILMSNDDGWATANIRAFYYKLKEAGhvYIVAPVTDMSGHGGQFDLPepMYGHEVDDDHVFYFNGTPASCVAFAFDYILPttIDMVVAGNNYAQNYGGYFSLSGTMGATIEAVYRGYPAIAFSAWSWNnyKdvAEKATELVNQIFESQGENpvGLNVNFPAVGYDNEScwVFTRIA----------------------------------------------------------------------------    
235 UniRef50_D1VKF7        Survival protein SurE n=1 T...   142     1e-32  1  28.0%   3:227  60:283     --ILVSNDDGVGAAGIDAVVTALRALPAVTvvAPATNQSGTGGKTSPTTPAhaTTASGVAATAVDGFPADSVNVALD-VLGVKPNLVVTGINQGQNLGPFVDLSGTVGAARAAAAHGIPALATSMGLGpdYSQAATLVTAWVTAHRagGAALSTVTNLNIPNCGAAKIRGER-----------ELATEPTVTDMATAITNGQDCSSTANPADEVGAFNAGFATLTTI--------------------------    
236 UniRef50_B9W8D0        Acid phosphatase,, putative...   141     3e-32  1  27.9%   2:180  20:247     -NILLTNDDGWQATNIRATYYKLKEAGhvFLVAPVSQRSGFSGKFDIPtpSWGHEVDDDHIWYFNGTPASSAVFGINYVIPntIDLVVSGPNEGTNMSPGLFtsGTVGATYTSIYRGIPGVAfsLDLKDDKEPSTIYANKIVEFVTqrALGLGVGLNVNFPKVGYENEtkWVFTRLTGQY-------------------------------------------------------------------------    
237 UniRef50_Q0K3N3        Predicted acid phosphatase ...   140     4e-32  1  26.5%   2:231  31:308     -NILLTNDDGCAAPGITAVRKALQDAGhvITVGPATNQSGSGAAYAVPdpLavHRVKATFvyLGSGSPVDATAMGLKIVGPetPDLVVSGANFGENLSDSIPHSGTVMNVLFAARRGVPGIALSVGVdaAFPRAGAFLARVIASLEATrlPVAHPLSINYPIAAGGTPAGVRLTTPGTVDSFTTAYKRNADNTVSIDVGAPETEAAALARIAETPAFLAKFITISALDVDF----------------------    
238 UniRef50_Q5KPW3        Cytoplasm protein, putative...   139     6e-32  1  22.2%   3:209  13:285     --VLLTNDDGpsSPNIYAFCKLLqrLgdVRVVIPDCQKSWVGKSynYFYPLelKEGESMEWVLLSGTPATCANIALHNIYPGQIDLVISGPNHGRNSStfALSSGTLGATLAASLshMPCIAISYgsDRVLELATETAVDVCQQLFDNWGEDKEvySINIPLVEakNERKIVSTEMWRNAYGRLFKTTkdPGDDPVQIAHGYMKSQDKP--------------------------------------------    
239 UniRef50_B3T6I5        Putative uncharacterized pr...   139     9e-32  1  34.4% 117:241   1:129     --------------------------------------------------------------------------------------------------------------------GAPSIAFSQIYDDnwATAEKWAGRVLKKLTAELWPTGVLINVNFPDVTARRVTGIEITRQGRRKIGSDMARGTDPRGEPYYWIGAQRREEPYRRGTDLEAVRRGAVSVTPLTMDLTHAPTLKKMK------------    
240 UniRef50_UPI00016ABAA1 stationary phase survival p...   136     7e-31  1  47.8% 133:245   2:114     ------------------------------------------------------------------------------------------------------------------------------------DAARVAAEIVRHYLDHPLPGQPLLNVNIPNLPYEELKGWRVTRLGKRHPSQPVIRQTNPRGEPIYWIGAAGDALDASEGTDFHATASGYVSITPLQLDLTHTQMLAATRDWAR--------    
241 UniRef50_P30887        Acid phosphatase n=3 Tax=Ya...   136     9e-31  1  27.7%   3:179  44:268     --IVVTNDDSWASANIRAFYDELKKEgnVFMFAPALQQSGTGGTFVLPKNTTLAkeKDDHIWYFDGTPGAAVTFGFDYALPktVDLVVSGPNEGWNLGPFVYtsGTEGAMYTSVLRGVPAIAFSGEnhTYYANaaKASTAIVKNLLKNalPYGVGLSVNLPLVGDIDPTGKcfTRQTGR--------------------------------------------------------------------------    
242 UniRef50_Q2GSR6        Putative uncharacterized pr...   131     2e-29  1  25.3%  54:231 119:347     -----------------------------------------------------TRRGTEEWILVDGTPASCVQIGLYHFFRDrvDLVVSGPNYGRntAVFALSSGTLGGALEAAVCKHRAVALSYafSRNHDtaTRQGVRVIEALVRDWPAdvDLYSVNVPLLEGLEKGKVLYTPMLQNYwhTHKHFKWSPRFTDVY-----QSVEEAPPGNDGWAVKEGHTSVTPLKANF----------------------    
243 UniRef50_Q0CEG2        Putative uncharacterized pr...   130     4e-29  1  25.9%   2:171  16:218     -NIISSNDDGWAEKNIRTLYDSLTTAGhvVISAPAENQSGKGSRDEPPSNLTeyNASQPHWNYVNSYPVTSMKHGIQTlfGGVPDLAVAGPNVGANIGLAVFLSGTVGATTYAAhaKIPAIAFSgeSTPAYSTiaDLAAKVTDRLVAAglPEDIWLNVNFPRVTDSSCTSV----------------------------------------------------------------------------------    
244 UniRef50_B2WGN4        Acid phosphatase n=3 Tax=Le...   130     4e-29  1  24.0%   1:233  22:303     LKILMGNDDGFGSGNLRELYKLLVGAGhvLIVAPAQQQSGKGTtlTVPSQYNIVPAgdDNIWYYDGTPAACTFVALDYVLpqTADLFIAGPNYGTNLGPFVmlSGTVGATIAAVSRSIPGFATSASNkpYFNVTgkVTFDIVNEFIKNtlPLGYGVNINLPELANGTMPPVVKSRLTGQ--ANTDVAVFNETTGLFTWDNVDPVagDTSLPGETWVVGGGSISVSAFTLDWSA--------------------    
245 UniRef50_B8N5N1        Acid phosphatase, putative ...   129     9e-29  1  26.5%   2:163  18:229     -NIISANDDGWAEKNIRTLYDTLTADGhvVISAPAENKSGTGmsPLLTQPLTLdnATQPRWNYVNSYPVTSIKYGIQNlfNGKPDLAVTGPNVGANLGVANAISGTVGAACYAAhaGIPAIAFSGSSGsaWDDpaQLATKVVDKVVAAglPEDVYLNVNFPKV------------------------------------------------------------------------------------------    
246 UniRef50_B8PDE4        Predicted protein n=1 Tax=P...   126     5e-28  1  34.6%   3:132  24:176     --VLLTNDDGWADAQIRAQYDElrAVFNVVLSSPSENQSGTG-STTATPTVLTEPCenPRINYVNAYPVDAAYYGIETlfGKKPDFVVSGPNIGNNLGTVVLESGTVGAACEAAKLGVPSTAFSGdqPSDYK-------------------------------------------------------------------------------------------------------------------------    
247 UniRef50_UPI0000382485 COG0496: Predicted acid pho...   126     1e-27  1  27.4% 111:245   1:142     --------------------------------------------------------------------------------------------------------------MEGTILGVRSIALSQagSLKWACAAEHGPQVIRKILEIGIEPGILINVNFPDCEPGEVKGVAVSAQGQRNQAlqIDARHDGRGNPYFWLAFAKARFEPGNGSDLKAIADNRISVTPLRLDLTDEPELTRFAKAFE--------    
248 UniRef50_D1NC77        Acid phosphatase surE n=2 T...   124     3e-27  1  50.0% 153:246  20:113     --------------------------------------------------------------------------------------------------------------------------------------------------------RVIININVPDLPFEELKGYKVCRLGYRASSAEVIKQKDPRDETIYWIGPSALPEDESEGTDFYAVKNGYVSITPIQADLTAYHSLLSLQNWLDQ-------    
249 UniRef50_B6H014        Pc12g13590 protein n=14 Tax...   121     2e-26  1  23.6%   2:166  17:214     -NIISSNDDGWAEANIRAFFEFLQAADhvVVSAPAENQSGKGSktVLTEPCQFNScsESRLGYVNSYPVTAIKYGIekFFNGAPDLAVTGPNVGSNIDIVNYFSGTVGAATYAAQNGIPALAFssGSPTSWDSpaDLATNLTNQVIAAglPDDIFLNVNFGKVTDE---------------------------------------------------------------------------------------    
250 UniRef50_Q4P1L8        Putative uncharacterized pr...   120     4e-26  1  23.9%   1:197 114:365     LNIVLTNDDSWASANVRALYYALRRAGhvLMVSPSHNQSGKGGTVVLPTELNItnVSDPGLRYFNGTPAACSGWALDHDAQYFfdLVVSGPNEGTNLGPFLYtsGTIGASYFAVERGVPSIAISASTDIRQYTsaTYSANFVTTVSDEalPLGIGLTVNYPkvPTGNCTDLTwtRLTGKAIVDRFVVNAT-TGLPTY--------------------------------------------------------    
251 UniRef50_Q5SLD2        Survival protein SurE n=1 T...   110     4e-23  1  40.4% 155:248    2:91     ----------------------------------------------------------------------------------------------------------------------------------------------------------LLNVNFPAS---RPKGLLVTRLSTHRFEDQVVERLDPEGKPYYWIAGTP-AGEEEEGTDLWAVRRGYVSVTPVSLDLTAHGFLEALSGLLEGVA-----    
252 UniRef50_A8KYH3        Survival protein SurE n=1 T...   105     2e-21  1  26.6%  40:227  56:242     ---------------------------------------GGGGKTTMPTPThaATAGGITATAVDGFPADAVTVALD-VLRLTPDLVVSGINQGQNLGPVVDLSGTVGAARAAASRGVPAIASSMGTGddFAPAVKLVTDWvsAGAPSSGPRATIANLNIPNCAA-----------GGRIRGERELPTQPALPDLAVALAPQDCTSSAEPGEEVAAFTAGFATLTEI--------------------------    
253 UniRef50_A2R311        Putative frameshift n=1 Tax...    97     7e-19  1  25.0%  54:169  62:195     -----------------------------------------------------HNSSQPRFNYVNSYPATSMKYGLNNlfSGSPDLAVAGPNVGANLGLAVFFSGTVGATTYAANQGIPAIAFSGYTGsaWNVsaELATKLVDELVESglPEGVWLNVNFGAVSDDSCT------------------------------------------------------------------------------------    
254 UniRef50_UPI00019070CB stationary phase survival p...    92     2e-17  1  40.8%    1:76    1:80     MKVLLTNDDGYQSPGVAAARDALIACgqVLTVAPDGPRSGTSRSASFRKAITMTKAGGDDvyVTNGTPTDCVRVAV---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
255 UniRef50_Q5K891        Cytoplasm protein, putative...    84     4e-15  1  19.0%   7:195  39:241     ------NDDGpsSPNIFSFAKTLQalgdVRVVIPDSQKSWC-----VAPPL-------PRAWTPDSPptGSAR-------------------HGRNSStfALSSGTIGAALAATleHVPCIALSYapPRLLALAAETSVDVCKRLFDNWGHDSviYSVNVPLVEEYLEKgaVYTELWKNAYGRLFKphFDPGDDP----------------------------------------------------------    
256 UniRef50_UPI000187DF26 hypothetical protein MPER_0...    67     6e-10  1  29.6%    2:82  33:133     -RILLTNDDGWATGAIRAQYEALRDAgqIILSAPAVDRSGTG-PLSADPVVVVDGCedARINYVNAFPADSVKFGIRTLAPK---------------------------------------------------------------------------------------------------------------------------------------------------------------------------    
257 UniRef50_A8IEK5        Predicted protein (Fragment...    64     4e-09  1  22.0%  75:192  10:140     --------------------------------------------------------------------------GLLRALDLHPIMALSGPNYGPNMGTDVLLRWTLTEMALSTLEGRPaiVTGGLGRRHVHSSCdwVMDVEQVLVDAFQDGDVFINLNVPA-QWQRGHGVQTTGLGLMFYRDSYVVSVPGR-------------------------------------------------------------    
258 UniRef50_B8PJW6        Predicted protein n=1 Tax=P...    58     3e-07  1  23.7%    3:95  24:103     --ILLTNDDGLVVAQISAQYRgmSFRGQVW--------NGVQNYYTHTR-----------VNYVNAYPVDAANYGIkkFFTKEPDFVDSGPNIGN--------------------------------------------------------------------------------------------------------------------------------------------------------------    
259 UniRef50_Q4FTW0        Putative uncharacterized pr...    46     0.001  1  37.8%   58:94   30:67     ---------------------------------------------------------PSGFIAVNGTPADGIYLALNELYPedFDCVITGINSG---------------------------------------------------------------------------------------------------------------------------------------------------------------    
260 UniRef50_A9SJL0        Predicted protein n=1 Tax=P...    44     0.004  1  28.6% 186:248  46:110     -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ESDKEPSPRMRFRLEGAEQELGaePDHDFGALQQGYVSITALGLD-THVEAtaQVEKWVAGVA-----    
261 UniRef50_A3LSW4        Acid phosphatase-like prote...    40     0.080  1  15.8%  58:171 145:290     ---------------------------------------------------------DANIWYVNSTPLNSLRVAFDVILPevPDVVIVGPNEGSSLTTSPEHTgtNLEAlaSLTKNITTVGIsfQDEKYFKIQanFINRKISQLLQgdLSKPVAVNVNFPSMNHESSRCI----------------------------------------------------------------------------------    
262 UniRef50_A0LKB8        Glycosyl transferase, group...    40     0.095  1  17.9% 102:185 300:386     -----------------------------------------------------------------------------------------------------LYEGTANAMLEAMVMGLPVVAFDIPAVHEFCPSETIVCPFAdkGLAQGLDRCLTLLSTTPtcPSPAFRQALVAKFSSRRWHQEL--------------------------------------------------------------------    
    consensus/100%                                                                                      .............................................................................................................................................................................................................................................................    
    consensus/90%                                                                                       ...h.sNDDG..t..h..h...h....ph.h.hP....oh.u.th.....h..........h.htutPsssh.huh..h.....shhluG.N.G.N.u.....SGThuushtu...th.uhuhS......ht....h...hht.h.........hhslNhP.........h..s.........................................................................          
    consensus/80%                                                                                       ..lLlsNDDGh.u.tl..hhp.htthtplhlssPttppSuhutshsh.tsh.h..ht...hh.hsGoPssss.huh..hh....DlllSG.N.G.Nhu..hhhSGTluuAhpuhh.sh.ulAhSh....pht.stthhhtlht.hhtt.h....hhslNhP.....t.t.hhhs..s.......h....t.....hh.............tsD..hh.tthhslo.h...................           
    consensus/70%                                                                                       .plLloNDDGhtu.GltsLhpthpthucVhlsAPtpppSuhupuhohtpslphpphtt.thhhlsGTPsDClhlulttlhttpsDlVlSGlNhGtNhu.phhhSGTluAAhEushhGlsulAhShst.tpap.usphshpllptlhtt.hstshhhNlNhPth..tp.pshthsp.utthhtt.h..t.sspsp.hhhht......t.t.ssDh.hl.pshlolTPlth................            

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown